10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2024

or

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from to

Commission File No. 0-22818

THE HAIN CELESTIAL GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware	22-3240619
(State or other jurisdiction of incorporation)	(I.R.S. Employer Identification No.)

221 River Street, Hoboken, NJ 07030

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (516) 587-5000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $.01 per share	HAIN	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

As of October 31, 2024, there were 90,194,130 shares outstanding of the registrant’s Common Stock, par value $.01 per share.

THE HAIN CELESTIAL GROUP, INC.

Index

	Part I - Financial Information	Page
Item 1.	Financial Statements	3
	Consolidated Balance Sheets - September 30, 2024 and June 30, 2024	3
	Consolidated Statements of Operations - Three months ended September 30, 2024 and 2023	4
	Consolidated Statements of Comprehensive Income (Loss) - Three months ended September 30, 2024 and 2023	5
	Consolidated Statement of Stockholders’ Equity - Three months ended September 30, 2024 and 2023	6
	Consolidated Statements of Cash Flows - Three months ended September 30, 2024 and 2023	8
	Notes to Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	40
Item 4.	Controls and Procedures	40
	Part II - Other Information
Items 3, and 4 are not applicable
Item 1.	Legal Proceedings	41
Item 1A.	Risk Factors	41
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 5.	Other Information	41
Item 6.	Exhibits	42
Signatures		43

1

Forward-Looking Statements

This Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q”) contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of The Hain Celestial Group, Inc. (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”) may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things: our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives and business strategy, including statements related to Hain Reimagined; our supply chain, including the availability and pricing of raw materials; our brand portfolio; pricing actions and product performance; inflation rates; and current or future macroeconomic trends.

Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; our ability to manage our supply chain effectively; input cost inflation, including with respect to freight and other distribution costs; disruption of operations at our manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences; customer concentration; our ability to execute our cost reduction initiatives and related strategic initiatives; reliance on independent distributors; risks associated with operating internationally; the availability of organic ingredients; risks associated with outsourcing arrangements; risks associated with geopolitical conflicts or events; our ability to identify and complete acquisitions or divestitures and our level of success in integrating acquisitions; our reliance on independent certification for a number of our products; our ability to attract and retain highly skilled people; risks related to tax matters; impairments in the carrying value of goodwill or other intangible assets; the reputation of our company and our brands; our ability to use and protect trademarks; foreign currency exchange risk; general economic conditions; compliance with our credit agreement; cybersecurity incidents; disruptions to information technology systems; the impact of climate change and related disclosure regulations; liabilities, claims or regulatory change with respect to environmental matters; pending and future litigation, including litigation relating to Earth’s Best® baby food products; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; compliance with data privacy laws; the adequacy of our insurance coverage; and other risks and matters described in our most recent Annual Report on Form 10-K, this Form 10-Q and other reports that we file in the future.

We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.

2

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

September 30, 2024 AND JUNE 30, 2024

(In thousands, except par values)

	September 30,			June 30,
	2024			2024
ASSETS
Current assets:
Cash and cash equivalents	$	56,853		$	54,307
Accounts receivable, less allowance for doubtful accounts of $1,511 and $1,517, respectively		188,190			179,190
Inventories		270,418			274,128
Prepaid expenses and other current assets		48,570			49,434
Total current assets		564,031			557,059
Property, plant and equipment, net		266,947			261,730
Goodwill		936,341			929,304
Trademarks and other intangible assets, net		250,179			244,799
Investments and joint ventures		10,080			10,228
Operating lease right-of-use assets, net		85,029			86,634
Other assets		22,202			27,794
Total assets	$	2,134,809		$	2,117,548
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	184,969		$	188,220
Accrued expenses and other current liabilities		88,160			85,714
Current portion of long-term debt		7,567			7,569
Total current liabilities		280,696			281,503
Long-term debt, less current portion		732,799			736,523
Deferred income taxes		45,397			47,826
Operating lease liabilities, noncurrent portion		78,905			80,863
Other noncurrent liabilities		33,351			27,920
Total liabilities		1,171,148			1,174,635
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none		—			—
Common stock - $.01 par value, authorized 150,000 shares; issued: 111,964 and 111,867 shares, respectively; outstanding: 89,907 and 89,846 shares, respectively		1,120			1,119
Additional paid-in capital		1,233,129			1,230,253
Retained earnings		557,856			577,519
Accumulated other comprehensive loss		(99,409	)		(137,245	)
		1,692,696			1,671,646
Less: Treasury stock, at cost, 22,057 and 22,021 shares, respectively		(729,035	)		(728,733	)
Total stockholders’ equity		963,661			942,913
Total liabilities and stockholders’ equity	$	2,134,809		$	2,117,548

See notes to consolidated financial statements.

3

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE MONTHS ENDED September 30, 2024 AND 2023

(In thousands, except per share amounts)

	Three Months Ended September 30,
	2024			2023
Net sales	$	394,596		$	425,029
Cost of sales		312,986			341,086
Gross profit		81,610			83,943
Selling, general and administrative expenses		71,328			77,169
Productivity and transformation costs		5,018			6,403
Amortization of acquired intangible assets		2,180			1,955
Long-lived asset impairment		31			694
Operating income (loss)		3,053			(2,278	)
Interest and other financing expense, net		13,746			13,244
Other expense (income), net		5,292			(265	)
Loss before income taxes and equity in net loss of equity-method investees		(15,985	)		(15,257	)
Provision (benefit) for income taxes		3,523			(5,379	)
Equity in net loss of equity-method investees		155			498
Net loss	$	(19,663	)	$	(10,376	)
Net loss per common share:
Basic	$	(0.22	)	$	(0.12	)
Diluted	$	(0.22	)	$	(0.12	)
Shares used in the calculation of net loss per common share:
Basic		89,861			89,512
Diluted		89,861			89,512

See notes to consolidated financial statements.

4

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

FOR THE THREE MONTHS ENDED September 30, 2024 AND 2023

(In thousands)

	Three Months Ended
	September 30, 2024									September 30, 2023
	Pretax amount			Tax benefit (expense)			After tax amount			Pretax amount			Tax (expense) benefit			After tax amount
Net loss							$	(19,663	)							$	(10,376	)
Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications	$	47,815		$	-		$	47,815		$	(32,933	)	$	-		$	(32,933	)
Change in deferred (losses) gains on cash flow hedging instruments		(9,702	)		2,438			(7,264	)		3,238			(794	)		2,444
Change in deferred gains (losses) on fair value hedging instruments		151			(38	)		113			(381	)		94			(287	)
Change in deferred (losses) gains on net investment hedging instruments		(3,777	)		949			(2,828	)		1,821			(452	)		1,369
Total other comprehensive income (loss)	$	34,487		$	3,349		$	37,836		$	(28,255	)	$	(1,152	)	$	(29,407	)
Total comprehensive income (loss)							$	18,173								$	(39,783	)

See notes to consolidated financial statements.

5

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE MONTHS ENDED September 30, 2024

(In thousands, except par values)

	Common Stock				Additional										Accumulated Other
			Amount		Paid-in		Retained			Treasury Stock					Comprehensive
	Shares		at $.01		Capital		Earnings			Shares		Amount			Loss			Total
Balance at June 30, 2024		111,867	$	1,119	$	1,230,253	$	577,519			22,021	$	(728,733	)	$	(137,245	)	$	942,913
Net loss								(19,663	)										(19,663	)
Other comprehensive income																37,836			37,836
Issuance of common stock pursuant to stock-based compensation plans		97		1															1
Employee shares withheld for taxes											36		(302	)					(302	)
Stock-based compensation expense						2,876													2,876
Balance at September 30, 2024		111,964	$	1,120	$	1,233,129	$	557,856			22,057	$	(729,035	)	$	(99,409	)	$	963,661

See notes to consolidated financial statements.

6

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023

(In thousands, except par values)

	Common Stock				Additional										Accumulated Other
			Amount		Paid-in		Retained			Treasury Stock					Comprehensive
	Shares		at $.01		Capital		Earnings			Shares		Amount			Loss			Total
Balance at June 30, 2023		111,339	$	1,113	$	1,217,549	$	652,561			21,864	$	(727,100	)	$	(126,216	)	$	1,017,907
Net loss								(10,376	)										(10,376	)
Other comprehensive loss																(29,407	)		(29,407	)
Issuance of common stock pursuant to stock-based compensation plans		239		3															3
Employee shares withheld for taxes											86		(875	)					(875	)
Stock-based compensation expense						3,742													3,742
Balance at September 30, 2023		111,578	$	1,116	$	1,221,291	$	642,185			21,950	$	(727,975	)	$	(155,623	)	$	980,994

See notes to consolidated financial statements.

7

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023

(In thousands)

	Three Months Ended September 30,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(19,663	)	$	(10,376	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		11,427			12,305
Deferred income taxes		(671	)		(11,269	)
Equity in net loss of equity-method investees		155			498
Stock-based compensation, net		2,876			3,742
Long-lived asset impairment		31			694
Loss on sale of assets		3,934			62
Other non-cash items, net		1,085			(556	)
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable		(3,926	)		(1,150	)
Inventories		2,282			(7,423	)
Other current assets		(2,471	)		8,761
Other assets and liabilities		579			(3,198	)
Accounts payable and accrued expenses		(6,425	)		21,940
Net cash (used in) provided by operating activities		(10,787	)		14,030
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(5,757	)		(6,906	)
Proceeds from sale of assets		12,066			1,257
Net cash provided by (used in) investing activities		6,309			(5,649	)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility		59,000			46,000
Repayments under bank revolving credit facility		(61,000	)		(57,000	)
Repayments under term loan		(1,875	)		(1,875	)
Payments of other debt, net		(21	)		(3,834	)
Employee shares withheld for taxes		(302	)		(875	)
Net cash used in financing activities		(4,198	)		(17,584	)
Effect of exchange rate changes on cash		11,222			(5,881	)
Net increase (decrease) in cash and cash equivalents		2,546			(15,084	)
Cash and cash equivalents at beginning of period		54,307			53,364
Cash and cash equivalents at end of period	$	56,853		$	38,280

See notes to consolidated financial statements.

8

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(Amounts in thousands, except par values and per share data)

1.BUSINESS

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”), was founded in 1993. Hain Celestial is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby & kids, beverages, meal preparation, and personal care are marketed and sold in over 70 countries around the world. The Company operates under two reportable segments: North America and International.

The Company’s leading brands include Garden Veggie Snacks™, Terra® chips, Garden of Eatin’® snacks, Hartley’s® Jelly, Earth’s Best® and Ella’s Kitchen® baby and kids foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, Greek Gods® yogurt, Cully & Sully®, Yorkshire Provender®, New Covent Garden® and Imagine® soups, Yves® and Linda McCartney’s® (under license) meat-free, and Avalon Organics® personal care, among others.

9

2. BASIS OF PRESENTATION

The Company’s unaudited consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net loss includes the Company's equity in the current earnings or losses of such companies.

The Company’s unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the “Form 10-K”). The amounts as of and for the periods ended June 30, 2024 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the three months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2025. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2024 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes.

All dollar amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousands, except par values and per share amounts, unless otherwise indicated.

Significant Accounting Policies

The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies.

Transfer of Financial Assets

The Company accounts for transfers of financial assets, such as non-recourse accounts receivable financing arrangements, when the Company has surrendered control over the related assets. Determining whether control has transferred requires an evaluation of relevant legal considerations, an assessment of the nature and extent of the Company’s continuing involvement with the assets transferred and any other relevant considerations. The Company has non-recourse financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivable in their entirety to the buyers and satisfied all of the conditions to report the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements was $56,959 and $86,506 during the three months ended September 30, 2024 and 2023, respectively. The incremental cost of financing receivables under these arrangements is included in selling, general and administrative expenses on the Company’s consolidated statements of operations. The proceeds from the sale of receivables are included in cash (used in) provided by operating activities on the consolidated statements of cash flows.

Recently Issued Accounting Pronouncements Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”. The amendments address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which will require entities to disclose more detailed information in the reconciliation of their statutory tax rate to their effective

10

tax rate. The ASU also requires entities to disclose more detailed information about income taxes paid, including by jurisdiction, pretax income (loss) from continuing operations, and income tax expense (benefit). The amendments are effective for fiscal years beginning after December 15, 2024 and for interim periods within fiscal years beginning after December 15, 2025. The amendments should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

3.LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share on the consolidated statements of operations:

	Three Months Ended September 30,
	2024			2023
Numerator:
Net loss	$	(19,663	)	$	(10,376	)
Denominator:
Basic and diluted weighted average shares outstanding		89,861			89,512
Basic and diluted net loss per common share	$	(0.22	)	$	(0.12	)

Due to the Company’s net loss in each of the three months ended September 30, 2024 and September 30, 2023, all common stock equivalents such as stock options, unvested restricted share units and performance share units have been excluded from the computation of diluted net loss per share. The effect of the stock options and unvested restricted share units would have been anti-dilutive to the computations. The performance share units were contingently issuable based on market conditions and such conditions had not been achieved during the respective periods.

4.DISPOSITION

ParmCrisps®

On August 30, 2024, the Company completed the sale of its ParmCrisps® business for total cash consideration of $12,000, subject to customary post-closing adjustments. The divestiture is consistent with the Company’s portfolio simplification process. ParmCrisps® was part of the Company’s North America reportable segment. During the three months ended September 30, 2024, the Company deconsolidated the net assets of ParmCrisps®, primarily consisting of $7,280, $6,725, and $1,282 of goodwill, inventory, and machinery and equipment, respectively, and recognized a pretax loss on sale of $3,863 recorded in other expense (income), net.

5.INVENTORIES

Inventories consisted of the following:

	September 30, 2024		June 30, 2024
Finished goods	$	178,863	$	178,150
Raw materials, work-in-progress, and packaging		91,555		95,978
	$	270,418	$	274,128

11

6.PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:

	September 30, 2024		June 30, 2024
Land	$	11,738	$	11,381
Buildings and improvements		59,381		57,030
Machinery and equipment		335,138		325,174
Computer hardware and software		54,940		54,139
Furniture and fixtures		21,830		20,943
Leasehold improvements		37,784		39,255
Construction in progress		11,534		12,783
		532,345		520,705
Less: Accumulated depreciation		265,398		258,975
	$	266,947	$	261,730

Depreciation expense for the three months ended September 30, 2024 and 2023 was $7,910 and $9,826, respectively.

7.LEASES

The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Western Europe. The Company determines if an arrangement is or contains a lease at inception. At September 30, 2024 and June 30, 2024, right of use assets related to finance leases are included in property, plant and equipment, net on the consolidated balance sheets. Lease liabilities for finance leases are included in the current and non-current portions of long-term debt on the consolidated balance sheets. Current portion of the operating lease liabilities are included in accrued expenses and other current liabilities on the consolidated balance sheets. The Company does not have any related party leases, and sublease transactions are de minimis.

The components of lease expenses for the three months ended September 30, 2024 and 2023 were as follows:

	Three Months Ended
	September 30, 2024		September 30, 2023
Operating lease expenses	$	4,109	$	4,578
Finance lease expenses		37		37
Variable lease expenses		173		182
Short-term lease expenses		426		395
Total lease expenses	$	4,745	$	5,192

12

8.GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:

	North America			International		Total
Balance as of June 30, 2024(1)	$	689,468		$	239,836	$	929,304
Divestiture(2)		(7,280	)		—		(7,280	)
Translation		514			13,803		14,317
Balance as of September 30, 2024	$	682,702		$	253,639	$	936,341

(1)The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $7,700 is related to the North America reportable segment and $126,577 is related to the International reportable segment.

(2) During the three months ended September 30, 2024, the Company completed the divestiture of ParmCrisps®, a component of the North America reportable segment. Goodwill of $7,280 was assigned to the divested component on a relative fair value basis.

As of September 30, 2024, the Company performed an assessment of factors to determine whether it was more likely than not that the fair value of its reporting units was less than its carrying amount, including goodwill. The Company concluded that were no events or circumstances that warranted an interim quantitative impairment test for goodwill during the three months ended September 30, 2024. As of September 30, 2024, goodwill associated with the U.S. reporting unit had a carrying value of $633,774. The U.S. reporting unit is at risk of potential impairment if, among other things, the fair value of this reporting unit, and its associated assets, decreases in value due to the amount and timing of expected future cash flows, decreased customer demand for products, an inability to execute management’s business strategies, or general market conditions, such as economic downturns, and changes in interest rates, including discount rates. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company’s estimates. If the Company’s ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record impairment charges in future periods.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:

	September 30, 2024			June 30, 2024
Non-amortized intangible assets:
Trademarks and tradenames(1)	$	201,407		$	195,237
Amortized intangible assets:
Other intangibles		169,560			167,886
Less: Accumulated amortization		(120,788	)		(118,324	)
Net amortized intangible assets		48,772			49,562
Net other intangible assets	$	250,179		$	244,799

(1) The gross carrying value of trademarks and tradenames is reflected net of $251,551 of accumulated impairment charges as of September 30, 2024 and June 30, 2024.

13

There were no events or circumstances that warranted an interim impairment test for indefinite-lived intangible assets during the three months ended September 30, 2024 or 2023.

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships, trademarks and tradenames and are amortized over their estimated useful lives of 7 to 25 years. The weighted average remaining amortization period of amortized intangible assets is 8.7 years.

Amortization expense included in the consolidated statements of operations is as follows:

	Three Months Ended September 30,
	2024		2023
Amortization of acquired intangibles	$	2,180	$	1,955

9.DEBT AND BORROWINGS

Debt and borrowings consisted of the following:

	September 30, 2024			June 30, 2024
Revolving credit facility	$	473,000		$	475,000
Term loans		268,675			270,550
Less: Unamortized issuance costs		(1,510	)		(1,680	)
Other borrowings(1)		201			222
		740,366			744,092
Short-term borrowings and current portion of long-term debt(2)		7,567			7,569
Long-term debt, less current portion	$	732,799		$	736,523

(1) Includes $201 (June 30, 2024: $222) of finance lease obligations.

(2) Includes $83 (June 30, 2024: $85) of short-term finance lease obligations.

Amended and Restated Credit Agreement

On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement (as amended, the “Credit Agreement”). The Credit Agreement provides for senior secured financing of $1,100 million in the aggregate, consisting of (1) $300 million in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and is comprised of a $440 million U.S. revolving credit facility and $360 million global revolving credit facility) (the “Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026. The Company’s obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions.

The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio. Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023 and 5.00:1.00 until December 31, 2024 (the period of time during which such maximum consolidated secured leverage ratios are in effect, the “Second Amendment Period”). Following the Second Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00. Pursuant to the Second Amendment, the Company’s minimum interest coverage ratio was amended to be 2.50:1.00.

During the Second Amendment Period, loans under the Credit Agreement bear interest at (a) Term SOFR plus 2.5% per annum or (b) the Base Rate plus 1.5% per annum. Following the Second Amendment Period, loans bear interest at rates based on (a) Term SOFR plus a rate ranging from 1.125% to 2.0% per annum or (b) the Base Rate plus a rate ranging from 0.125% to 1.0% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Second Amendment

14

Period is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement as amended by the Second Amendment. Excluding the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2024 was 7.76%. During fiscal 2022, the Company used interest rate swaps to hedge a portion of the interest rate risk related its outstanding variable rate debt. As of September 30, 2024, the notional amount of the interest rate swaps was $400 million with fixed rate payments of 5.60%. Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2024 was 6.56%. Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

As of September 30, 2024, there were $473,000 of loans under the Revolver, $268,675 of Term Loans, and $3,247 of letters of credit outstanding under the Credit Agreement. As of September 30, 2024, $323,753 was available under the Credit Agreement, subject to compliance with the financial covenants. As of September 30, 2024, the Company was in compliance with all associated covenants.

Credit Agreement Issuance Costs

In connection with the First and Second Amendments to its Credit Agreement during the second quarter of fiscal year 2023 and first quarter of fiscal year 2024, respectively, the Company incurred debt issuance costs of approximately $5,841, of which $5,729 was deferred. Of the total deferred costs, $4,198 were associated with the Revolver and are being amortized on a straight-line basis within Other assets on the consolidated balance sheets, and $1,531 are being recorded as an adjustment to the carrying amount of the Term Loans as a component of Interest and other financing expense, net over the term of the Credit Agreement utilizing the effective interest rate method.

Interest paid during the three months ended September 30, 2024 and September 30, 2023 was $12,455 and $11,432, respectively.

10.INCOME TAXES

In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. However, to the extent that application of the estimated annual effective tax rate is not representative of the quarterly portion of actual tax expense expected to be recorded for the year in a jurisdiction, the Company determines the provision for income taxes based on actual year-to-date income (loss), which has been the case for certain jurisdictions for the quarter ended September 30, 2024. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

The effective income tax rate was an expense of 22.0% and a benefit of 35.3% for the three months ended September 30, 2024 and 2023, respectively. The income tax expense for the three months ended September 30, 2024 reflected foreign tax expense in certain jurisdictions and an increase in the valuation allowance for both federal and state income taxes.

15

11.ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table presents the changes in accumulated other comprehensive loss (“AOCL”):

	Foreign Currency Translation Adjustment, Net			Deferred Gains (Losses) on Cash Flow Hedging Instruments, Net			Deferred Gains (Losses) on Fair Value Hedging Instruments, Net			Deferred Gains (Losses) on Net Investment Hedging Instruments, Net			Total
Balance at June 30, 2023	$	(138,028	)	$	10,898		$	685		$	229		$	(126,216	)
Other comprehensive (loss) income before reclassifications		(32,933	)		4,159			430			1,741			(26,603	)
Amounts reclassified into income		—			(1,715	)		(717	)		(372	)		(2,804	)
Net change in accumulated other comprehensive (loss) income for the three months ended September 30, 2023(1)		(32,933	)		2,444			(287	)		1,369			(29,407	)
Balance at September 30, 2023	$	(170,961	)	$	13,342		$	398		$	1,598		$	(155,623	)
Balance at June 30, 2024	$	(147,073	)	$	9,395		$	297		$	136		$	(137,245	)
Other comprehensive income (loss) before reclassifications		47,815			(5,515	)		(606	)		(2,457	)		39,237
Amounts reclassified into (income) expense		—			(1,749	)		719			(371	)		(1,401	)
Net change in accumulated other comprehensive income (loss) for the three months ended September 30, 2024(1)		47,815			(7,264	)		113			(2,828	)		37,836
Balance at September 30, 2024	$	(99,258	)	$	2,131		$	410		$	(2,692	)	$	(99,409	)

(1) See Note 14, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains on hedging instruments recorded in the consolidated statements of operations during the three months ended September 30, 2024 and 2023.

12.STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company maintains a shareholder-approved plan, The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (as amended, the “2022 Plan”), which was approved at the Company’s 2022 Annual Meeting of Shareholders held on November 17, 2022, and further amended at the Company’s 2024 Annual Meeting of Shareholders held on October 31, 2024. The 2022 Plan permits the Company to continue making equity-based and other incentive awards in a manner intended to properly incentivize its employees, directors, consultants and other service providers by aligning their interests with the interests of the Company’s shareholders. The 2022 Plan is administered by the Compensation and Talent Management Committee of the Company’s Board of Directors. The Company also historically granted shares under its Amended and Restated 2002 Long-Term Incentive and Stock Award Plan (the “2002 Plan”) and its 2019 Equity Inducement Award Program (the “2019 Inducement Program”). The 2022 Plan, the 2002 Plan and the 2019 Inducement Program are collectively referred to as the “Stock Award Plans”. The Company’s long term incentive program (“LTIP”) is described in Note 13, Stock-Based Compensation and Incentive Performance Plans, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Compensation cost and related income tax benefits recognized in the consolidated statements of operations for stock-based compensation plans were as follows:

	Three Months Ended September 30,
	2024		2023
Selling, general and administrative expense	$	2,876	$	3,742
Related income tax benefit	$	283	$	456

16

Stock-Based Award Activity

Stock-based awards are generally issued in the form of restricted share units (“RSU”), which are service-based awards, and performance share units (“PSU”) that are subject to the achievement of minimum market conditions. RSU awards to employees generally provide for vesting in equal annual installments over a period of three years, with different vesting periods in certain cases. RSU awards to non-employee directors generally provide for a vesting period of one year. For PSU awards, the following share figures are stated at target levels, and the awards outstanding as of September 30, 2024 generally provide for vesting at 0% to 200% of the target level. Awards of PSUs and RSUs are issued at no cost to the recipient. A summary of all stock-based award activity for the three months ended September 30, 2024 is as follows:

	Number of Shares and Units			Weighted Average Grant Date Fair Value (per share)
Non-vested RSUs and PSUs outstanding at June 30, 2024		2,165		$	15.03
Granted		12		$	7
Vested		(97	)	$	18.15
Forfeited		(69	)	$	15.14
Non-vested RSUs and PSUs outstanding at September 30, 2024		2,011		$	14.83

The fair value of RSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting was as follows:

	Three Months Ended September 30,
	2024		2023
Fair value of RSUs granted	$	86	$	—
Fair value of shares vested	$	823	$	2,422
Tax benefit recognized from restricted shares vesting	$	100	$	281

At September 30, 2024, there was $15,518 of unrecognized stock-based compensation expense related to non-vested restricted stock awards, which is expected to be recognized over a weighted average period of 1.8 years.

13.FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of September 30, 2024:

	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	$	5,397	$	—	$	5,397	$	—
Liabilities:
Derivative financial instruments	$	8,159		—	$	8,159		—

17

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:

	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	$	14,982	$	—	$	14,982	$	—
Liabilities:
Derivative financial instruments	$	3,333		—	$	3,333		—

There were no transfers of financial instruments between the three levels of fair value hierarchy during the three months ended September 30, 2024 or 2023.

Derivative Instruments

The Company uses interest rate swaps to manage interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage exposure to currency fluctuations. These instruments are valued using techniques like discounted cash flow analysis, which considers the contractual terms and market-based inputs such as interest rate curves and implied volatilities. The fair values of interest rate swaps are determined by netting the discounted future fixed and variable cash flows. The variable cash flows are based on expected future interest rates.

Credit valuation adjustments are made to reflect the nonperformance risk of both the Company and its counterparties. Most inputs used to value derivatives fall within Level 2 of the fair value hierarchy, but credit valuation adjustments use Level 3 inputs, such as current credit spreads. The impact of these adjustments was not significant to the overall valuation, so all derivatives as of September 30, 2024 and June 30, 2024 were classified as Level 2.

Nonrecurring Fair Value Measurements

The Company measures certain non-financial assets, such as goodwill, intangible assets, property and equipment, and right-of-use lease assets, at fair value on a nonrecurring basis. These assets are initially measured at fair value at the time of acquisition or purchase, with adjustments only for foreign currency translation. Periodically, these assets are tested for impairment by comparing their carrying values to their estimated fair values. If an asset is impaired, the Company recognizes an impairment expense equal to the excess of the carrying value over the estimated fair value.

For indefinite-lived intangible assets, the fair value is determined using the relief from royalty approach, considering factors like future growth, royalty rates, discount rates, and other variables. Fair value measurements for reporting units are estimated using discounted cash flow models, which involve significant management judgment and Level 3 inputs, such as economic conditions and customer demand. These measurements are performed at least annually for impairment testing. The Company bases its fair value estimates on reasonable assumptions but acknowledges their unpredictability and inherent uncertainty.

14.DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposures to a wide variety of business and operational risks. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s receivables and borrowings.

Certain of the Company’s foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company’s cash receipts and payments in terms of the Company’s functional currency. The Company

18

enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. Dollar. Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During the three months ended September 30, 2024 and 2023, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate debt. During the next 12 months, the Company estimates that an additional $3,010 will be reclassified as a decrease to interest expense.

As of September 30, 2024, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

Interest Rate Derivative	Number of Instruments	Notional Amount
Interest rate swap	4	$	400,000

Cash Flow Hedges of Foreign Exchange Risk

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company, at times, uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange risks.

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the same period during which the hedged transaction affects earnings within the same income statement line item as the earnings effect of the hedged transaction. During the next 12 months, the Company estimates that no amount relating to the foreign currency forward contracts will be reclassified to interest expense. As of September 30, 2024, the Company had no outstanding foreign currency derivatives that were used to hedge its foreign exchange risks.

19

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Western Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency- fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in AOCL as part of the cumulative translation adjustment. Amounts are reclassified out of AOCL into earnings when the hedged net investment is either sold or substantially liquidated.

As of September 30, 2024, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

Foreign Currency Derivative	Number of Instruments	Notional Sold		Notional Purchased
Cross-currency swap	4	€	100,300	$	105,804

Fair Value Hedges

The Company is exposed to changes in the fair value of certain of its foreign denominated intercompany loans due to changes in foreign exchange spot rates. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in foreign exchange rates affecting gains and losses on intercompany loan principal and interest. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency-fixed-rate payments over the life of the agreement.

For derivatives designated and that qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in interest and other financing expense, net.

Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis, as documented at hedge inception in accordance with the Company’s accounting policy election. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction. During the next 12 months, the Company estimates that an additional $476 relating to cross currency swaps will be reclassified as a decrease to interest expense.

As of September 30, 2024, the Company had the following outstanding foreign currency derivatives that were used to hedge changes in fair value attributable to foreign exchange risk:

Foreign Currency Derivative	Number of Instruments	Notional Sold		Notional Purchased
Cross-currency swap	1	€	24,700	$	26,021

As of September 30, 2024 and June 30, 2024, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustment for fair value hedges:

	Carrying Amount of the Hedged Asset				Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset
	September 30, 2024		June 30, 2024		September 30, 2024		June 30, 2024
Intercompany loan receivable	$	27,548	$	26,465	$	1,083	$	(480	)

20

Designated Hedges

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheet as of September 30, 2024:

	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	3,008	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets		—	Other noncurrent liabilities		104
Cross-currency swaps	Prepaid expenses and other current assets		2,389	Accrued expenses and other current liabilities		—
Cross-currency swaps	Other noncurrent assets		—	Other noncurrent liabilities		8,055
Total derivatives designated as hedging instruments		$	5,397		$	8,159

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheet as of June 30, 2024:

	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	7,455	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets		5,151	Other noncurrent liabilities		—
Cross-currency swaps	Prepaid expenses and other current assets		2,376	Accrued expenses and other current liabilities		—
Cross-currency swaps	Other noncurrent assets		—	Other noncurrent liabilities		3,333
Total derivatives designated as hedging instruments		$	14,982		$	3,333

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL for the three months ended September 30, 2024 and 2023:

Derivatives in Cash Flow Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Reclassified from AOCL into Income	Amount of Gain Reclassified from AOCL into Income
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Interest rate swaps	$	(7,366	)	$	5,478	Interest and other financing expense, net	$	2,336	$	2,281
Foreign currency forward contracts		—			41	Cost of sales		—		—
	$	(7,366	)	$	5,519		$	2,336	$	2,281

21

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the consolidated statements of operations for the three months ended of September 30, 2024 and 2023:

	Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023
	Interest and other financing expense, net		Interest and other financing expense, net
The effects of cash flow hedging:
Gain on cash flow hedging relationships
Interest rate swaps
Amount of gain reclassified from AOCL into income	$	2,336	$	2,281

The following table presents the pre-tax effect of fair value hedge accounting on AOCL for the three months ended September 30, 2024 and 2023:

Derivatives in Fair value Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Cross-currency swaps	$	(809	)	$	572	Interest and other financing expense, net	$	123	$	123
	$	(809	)	$	572		$	123	$	123

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing fair value hedge accounting on the consolidated statements of operations as of September 30, 2024 and 2023:

	Location and Amount of (Loss) Gain Recognized in the Consolidated Statements of Operations on Fair Value Hedging Relationships
	Three Months Ended September 30, 2024			Three Months Ended September 30, 2023
	Interest and other financing expense, net			Interest and other financing expense, net
The effects of fair value hedging:
Gain on fair value hedging relationships
Cross-currency swaps
Amount of (loss) gain reclassified from AOCL into (expense) income	$	(960	)	$	953

22

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the consolidated statements of operations for the three months ended September 30, 2024 and 2023:

Derivatives in Net Investment Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Cross-currency swaps	$	(3,282	)	$	2,316	Interest and other financing expense, net	$	495	$	495

15.TRANSFORMATION PROGRAM - HAIN REIMAGINED

During the first quarter of fiscal year 2024, the Company initiated a multi-year growth, transformation and restructuring program (the “Hain Reimagined Program”). The Hain Reimagined Program is intended to optimize the Company’s portfolio, improve underlying profitability and increase its flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. The savings initiatives are expected to impact the Company’s reportable segments and Corporate and Other. Implementation of the Hain Reimagined Program is expected to be completed by the end of the 2027 fiscal year and is comprised of: contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses.

For the three months ended September 30, 2024, expenses associated with the Hain Reimagined Program in the amount of $5,018, $376, and $31, respectively, were recorded in productivity and transformation costs, cost of sales, and intangibles and long-lived asset impairment, respectively, on the consolidated statements of operations. For the three months ended September 30, 2023, expenses associated with the Hain Reimagined Program in the amount of $6,403 and $3,320, respectively, were recorded in productivity and transformation costs and cost of sales, respectively, on the consolidated statements of operations.

The table below sets forth expenses associated with the Hain Reimagined Program for the period ended September 30, 2024 and September 30, 2023 by reportable segments and Corporate and Other.

	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023
North America	$	2,241	$	3,358
Corporate and Other		1,990		5,770
International		1,194		595
	$	5,425	$	9,723

The following table displays the activities and liability balances relating to the Hain Reimagined Program for the period ended as of September 30, 2024. The Company expects to pay the remaining accrued restructuring costs during the next 12 months.

	Balance at June 30, 2024		Charges		Amounts Paid			Non-cash settlements/ Adjustments			Balance at September 30, 2024
Employee-related costs	$	1,985	$	2,280	$	(2,820	)	$	—		$	1,445
Contract termination costs		347		367		(8	)		(70	)		636
Asset write-downs1		—		31		—			(31	)		—
Other transformation-related expenses2		3,988		2,747		(2,454	)		(600	)		3,681
	$	6,320	$	5,425	$	(5,282	)	$	(701	)	$	5,762

23

1Represents non-cash asset write-downs including asset impairment and accelerated depreciation.
2Other transformation-related expenses primarily include consultancy charges related to reorganization of global functions and related personnel resource requirements, and rationalizing sourcing and supply chain processes.

16.COMMITMENTS AND CONTINGENCIES

Securities Class Actions Filed in Federal Court

On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York (the “District Court”) against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934: (1) Flora v. The Hain Celestial Group, Inc., et al.; (2) Lynn v. The Hain Celestial Group, Inc., et al.; and (3) Spadola v. The Hain Celestial Group, Inc., et al. (collectively, the “Securities Complaints”). The Securities Complaints were ultimately consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. During the summer of 2017, a Corrected Consolidated Amended Complaint was filed, which named as defendants the Company and certain of its former officers (collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and Securities and Exchange Commission (“SEC”) filings regarding the Company’s business, prospects, financial results and internal controls.

After Defendants’ initial motion to dismiss was granted without prejudice to replead in October 2017, the Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second Amended Complaint”). The Second Amended Complaint again named as defendants the Company and certain of its former officers and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations similar to those in the Corrected Consolidated Amended Complaint. Defendants filed a motion to dismiss the Second Amended Complaint on June 20, 2019. On April 6, 2020, the District Court granted Defendants’ motion to dismiss the Second Amended Complaint in its entirety, with prejudice. Co-Lead Plaintiffs appealed the District Court’s decision dismissing the Second Amended Complaint to the United States Court of Appeals for the Second Circuit (the “Second Circuit”). By decision dated December 17, 2021, the Second Circuit vacated the District Court’s judgment and remanded the case for further proceedings. The parties ultimately submitted supplemental briefing between May 12, 2022 and June 23, 2022, and in June 2022, the District Court referred Defendants’ Motion to Dismiss the Second Amended Complaint to a United States Magistrate Judge (the “Magistrate Judge”) for a Report and Recommendation. On November 4, 2022, the Magistrate Judge issued a Report and Recommendation recommending that the District Court grant Defendants’ Motion to Dismiss the Second Amended Complaint with prejudice. On September 29, 2023, the District Court granted Defendants’ Motion to Dismiss the Second Amended Complaint. Co-Lead Plaintiffs filed notice of appeal on October 26, 2023, appealing the District Court’s decision dismissing the Second Amended Complaint to the Second Circuit. Co-Lead Plaintiffs filed their opening brief on February 12, 2024. Defendants opposed, and the appeal was fully briefed as of June 3, 2024. The Court has scheduled oral argument on Plaintiffs’ appeal for December 5, 2024.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

The former Board of Directors and certain former officers of the Company are defendants in a consolidated action originally filed in 2017 in the Eastern District of New York under the captions Silva v. Simon, et al., Barnes v. Simon, et al., Merenstein v. Heyer, et al., and Oliver v. Berke, et al. Plaintiffs in the consolidated action, In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”), allege the violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment. The plaintiffs alleged in their Amended Complaint that the Company’s former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results and that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste.

On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to dismiss the Amended Complaint in the Consolidated Securities Action, described above. After the District Court granted Defendants’ motion to dismiss the Consolidated Securities Action, the Co-Lead Plaintiffs in that action filed a Second Amended Complaint on May 6, 2019. The

24

parties to the Consolidated Stockholder Class and Derivative Action thereby agreed to continue the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through 30 days after a decision on Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action.

On April 6, 2020, the District Court granted Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action, with prejudice. Pursuant to the terms of an agreed-upon stay, Defendants in the Consolidated Stockholder Class and Derivative Action had until May 6, 2020 to answer, move, or otherwise respond to the complaint in this matter. This deadline was extended, and Defendants moved to dismiss the Consolidated Stockholder Class and Derivative Action Complaint on June 23, 2020, with Plaintiffs’ opposition due August 7, 2020.

On July 24, 2020, Plaintiffs made a stockholder litigation demand on the current Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On November 3, 2020, Plaintiffs were informed that the Board of Directors had finished investigating and resolved, among other things, that the demand should be rejected. In light of the Second Circuit vacating the District Court’s judgment in the Consolidated Securities Action referenced above and remanding the case for further proceedings, the Parties submitted a joint status report on December 29, 2021 requesting that the District Court continue the temporary stay pending the District Court’s reconsideration of the Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action. The parties have most recently agreed to extend the stay through the earlier of November 8, 2024 or 30 days after the Second Circuit issues a decision on Plaintiffs’ currently pending appeal.

Baby Food Litigation

Since February 2021, the Company has been named in numerous consumer class actions alleging that the Company’s Earth’s Best® baby food products (the “Products”) contain unsafe and undisclosed levels of various naturally occurring heavy metals, namely lead, arsenic, cadmium and mercury. Those actions have now been transferred and consolidated as a single lawsuit in the U.S. District Court for the Eastern District of New York captioned In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678 (the “Consolidated Proceeding”), which generally alleges that the Company violated various state consumer protection laws and asserts other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals, arguing that consumers would have either not purchased the Products or would have paid less for them had the Company made adequate disclosures. The Company filed a motion to dismiss the Consolidated Class Action Complaint on November 7, 2022, which was opposed by the plaintiffs. On May 9, 2023, upon consent of the parties, the Court stayed the Consolidated Proceeding pending the Second Circuit’s decision on appeal in In re Beech-Nut Nutrition Co. Baby Food Litigation, 21 Civ. 133 (N.D.N.Y.) (the “Beech-Nut Case”). Accordingly, the Court denied the Company’s motion to dismiss without prejudice to renew.

By summary order dated January 18, 2024, the Second Circuit vacated the judgment dismissing the Beech-Nut Case and remanded for further proceedings. On February 15, 2024, the Company served a renewed motion to dismiss the Consolidated Proceeding. Plaintiffs served their opposition on March 14, 2024, and the Company served its reply on April 4, 2024. The Court heard oral argument on the motion to dismiss on August 1, 2024, and took the motion under submission. One consumer class action is pending in New York Supreme Court, Nassau County, which the court has stayed in deference to the Consolidated Proceeding. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled.

The claims raised in these lawsuits were brought in the wake of a highly publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the “House Report”), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publication of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and has provided documents and other requested information.

The Company has been named in one civil government enforcement action, State of New Mexico ex rel. Balderas v. Nurture, Inc., et al., which was filed by the New Mexico Attorney General against the Company and several other manufacturers based on the alleged presence of heavy metals in their baby food products. The Company and several other manufacturers moved to dismiss the New Mexico Attorney General’s lawsuit, and the Court denied that motion. The Company filed its answer to the New

25

Mexico Attorney General’s amended complaint on April 23, 2022, and discovery is set to commence. The Company denies the New Mexico Attorney General’s allegations and maintains that its baby foods are safe, properly labeled, and compliant with New Mexico law.

In addition to the consumer class actions discussed above, the Company is currently named in numerous lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company’s Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. These lawsuits generally allege injuries related to neurological development disorders such as autism and attention deficit hyperactivity disorder.

Multidistrict Litigation

•On January 4, 2024, Plaintiffs in federal cases across the country filed a Motion to Transfer Actions Pursuant to 28 U.S.C. § 1407 for Coordinated or Consolidated Pretrial Proceedings. On April 11, 2024, the United States Judicial Panel on Multidistrict Litigation granted Plaintiffs’ Motion and transferred the cases to the Northern District of California for coordinated or consolidated pretrial proceedings. In Re: Baby Food Products Liability Litigation (MDL No. 3101) has been assigned to District Judge Jacqueline Scott Corley. On April 15, 2024, Judge Corley issued Pretrial Order No. 1 staying all outstanding discovery proceedings and pending motions and vacating all previously scheduled hearing dates. There are approximately 24 federal cases filed against the Company pending in the multi-district litigation (“MDL”). Plaintiffs filed their Master Complaint on July 15, 2024. The MDL will first proceed with general causation discovery.

California State Court Cases

•There are currently seven cases against the Company pending in California state court, including six in Los Angeles Superior Court and one in Alameda Superior Court. The Plaintiffs filed a Petition for Coordination to the Chair of the Judicial Council seeking to coordinate the Alameda Superior Court and Los Angeles Superior Court cases. The Judicial Council granted the JCCP petition and on June 4, 2024, Judge Lawrence P. Riff (Los Angeles Superior Court) was assigned as trial coordination judge. All but one of the cases have been stayed.

•In one of the Los Angeles cases, Landon R. v. The Hain Celestial Group, Inc., et al., No. 23STCV24844, fact discovery has closed, and expert discovery is ongoing. The Court vacated the original January 2025 trial date, and a new trial date has not been set.

Other Cases

•In the matter Palmquist v. The Hain Celestial Group, Inc., a jury trial commenced on February 6, 2023 in the United States District Court for the Southern District of Texas. The Company moved for Directed Verdict at the close of Plaintiffs’ case. The Court granted the Company’s motion, finding no liability for the Company. The Court entered Final Judgment in the Company’s favor on March 3, 2023. On April 3, 2023, Plaintiffs filed their Notice of Appeal in the Fifth Circuit. Plaintiffs appealed, and on May 28, 2024, the Fifth Circuit reversed the district court’s order denying Plaintiff’s motion to remand the case and vacated the final judgement of the district court. the Company filed a petition for en banc reconsideration, which the Fifth Circuit denied. The case has been remanded to Texas state court. The Company expects to petition the Supreme Court of the United States for a writ of certiorari.

•In NC v. The Hain Celestial Group, et al., in the Superior Court for the State of California, County of Los Angeles, judgment was entered on October 26, 2023 in favor of the defendants as a result of successful defense pretrial motions, including the Company’s motion for summary judgment. The time for appeal has passed.

The Company denies that its Products led to any of the alleged injuries and will defend these cases vigorously. That said, as is common in circumstances of this nature, additional lawsuits may be filed against the Company in the future, asserting similar or different legal theories and seeking similar or different types of damages and relief. Such lawsuits may be resolved in a manner adverse to us, and we may incur substantial costs or damages not covered by insurance, which could have a material adverse effect on our financial condition and business.

26

SEC Investigation

In November 2023, the staff of the SEC informed the Company it was conducting an investigation relating to Hain Celestial and requested documents primarily concerning (i) the Company’s acquisition of one business and disposition of another business and certain related accounting matters and (ii) trading activity and other matters related to the Company’s earnings guidance in certain previous fiscal years. The Company is cooperating with the SEC in this investigation.

Other

In addition to the matters described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business.

With respect to all litigation and related matters, the Company records a liability when the Company believes it is probable that a liability has been incurred and the amount can be reasonably estimated. As of the end of the period covered by this report, the Company has not recorded a liability for any of the matters disclosed in this note. It is possible that some matters could require the Company to pay damages, incur other costs or establish accruals in amounts that could not be reasonably estimated as of the end of the period covered by this report.

17.SEGMENT INFORMATION

The Company’s organizational structure consists of two geographic based reportable segments: North America and International, which are also the operating segments. This structure is in line with how the Company’s Chief Operating Decision Maker (“CODM”) assesses the Company’s performance and allocates resources. The Company uses segment net sales and segment Adjusted EBITDA in order to analyze segment results and trends.

Segment Adjusted EBITDA excludes net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses, certain litigation and related costs, plant closure related costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, loss on sale of assets, long-lived asset impairments and other adjustments. In addition, Segment Adjusted EBITDA does not include Corporate and Other expenses related to the Company’s centralized administrative functions, which do not specifically relate to a reportable segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to the entire enterprise, litigation expense and expenses for certain professional fees, facilities, and other items which benefit the Company as a whole.

27

The following tables set forth financial information about each of the Company’s reportable segments. Information about total assets by segment is not disclosed because such information is not reported to or used by the Company’s CODM for purposes of assessing segment performance or allocating resources. Transactions between reportable segments were insignificant for all periods presented.

	Three Months Ended September 30,
	2024			2023
Net Sales:
North America	$	231,140		$	260,054
International		163,456			164,975
	$	394,596		$	425,029
Adjusted EBITDA:
North America	$	12,459		$	18,727
International		20,370			17,438
Total Reportable Segments Adjusted EBITDA		32,829			36,165
Corporate and Other		(10,454	)		(12,075	)
		22,375			24,090
Depreciation and amortization		(11,427	)		(12,305	)
Equity in net loss of equity-method investees		(155	)		(498	)
Interest expense, net		(12,995	)		(12,623	)
(Provision) benefit for income taxes		(3,523	)		5,379
Stock-based compensation, net		(2,876	)		(3,742	)
Unrealized currency losses		(1,194	)		(35	)
Certain litigation expenses, net(a)		(827	)		(1,524	)
Restructuring activities
Productivity and transformation costs		(5,018	)		(6,403	)
Plant closure related costs, net		(376	)		(1,841	)
Acquisitions, divestitures and other
Loss on sale of assets		(3,934	)		(62	)
Transaction and integration costs, net		318			(118	)
Impairment charges
Long-lived asset impairment		(31	)		(694	)
Net loss	$	(19,663	)	$	(10,376	)

(a) Expenses and items relating to securities class action, baby food litigation and SEC investigation.

The Company’s net sales by product category are as follows:

	Three Months Ended September 30,
	2024		2023
Snacks	$	99,475	$	117,088
Baby & Kids		60,768		62,528
Beverages		56,676		56,148
Meal preparation		159,392		165,196
Personal care		18,285		24,069
	$	394,596	$	425,029

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, are as follows:

	Three Months Ended September 30,
	2024		2023
United States	$	202,773	$	230,659
United Kingdom		122,406		121,051
Western Europe		41,050		43,924
Canada		28,367		29,395
	$	394,596	$	425,029

There has been no material change to Company’s total assets by segment from the amount disclosed in the Form 10-K for the fiscal year ended June 30, 2024.

28

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Consolidated Financial Statements and the related Notes thereto for the period ended September 30, 2024 contained in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. Forward-looking statements in this Form 10-Q are qualified by the cautionary statement included in this Form 10-Q under the sub-heading “Forward-Looking Statements” in the introduction of this Form 10-Q.

Overview

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”), is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby & kids, beverages, meal preparation, and personal care, are marketed and sold in over 70 countries around the world. The Company operates under two reportable segments: North America and International.

The Company’s leading brands include Garden Veggie Snacks™, Terra® chips, Garden of Eatin’® snacks, Hartley’s® Jelly, Earth’s Best® and Ella’s Kitchen® baby and kids foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, Greek Gods® yogurt, Cully & Sully®, Yorkshire Provender®, New Covent Garden® and Imagine® soups, Yves® and Linda McCartney’s® (under license) meat-free, and Avalon Organics® personal care, among others.

Hain Reimagined Program

During the first quarter of fiscal year 2024, we initiated a multi-year growth, transformation and restructuring program (the “Hain Reimagined Program”) intended to drive shareholder returns. The savings initiatives impact our reportable segments and Corporate and Other. The program is intended to optimize our portfolio, improve underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. The Hain Reimagined Program is grounded on four strategic pillars:

•Focus

oConcentrate our portfolio in five consumer-centric Better-For-You (“BFY”) platforms: Snacks, Baby & Kids, Beverages, Meal Preparation, and Personal Care.

oSimplify our footprint, maintaining direct presence in five key markets – United States (“U.S.”), Canada, United Kingdom (“U.K.”), Ireland, and Western Europe – and align our global operating model and footprint, leveraging scale and realizing synergies across the business.

•Grow

oDeliver share gain in key platforms where we have the most compelling right to win, through expanded channel reach and acceleration in our innovation pipeline.

•Build

oEnhance critical capabilities in brand building and effectiveness of marketing spend; expand reach across under-penetrated margin-accretive channels such as away-from-home and omni-channel e-commerce; and enhance our innovation capability to be more leading edge in BFY.

•Fuel

oDrive revenue growth management, working capital management and operational efficiency to fund growth and enhance margins.

Implementation of the Hain Reimagined Program is expected to be completed by the end of the 2027 fiscal year. Cumulative pretax charges associated with the Hain Reimagined Program are expected to be $115 million - $125 million inclusive of potential inventory write-downs of approximately $25 million related to brand/category exits. The balance of cumulative pretax restructuring charges is expected to be $90 million - $100 million comprised of contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses. For the three months ended September 30, 2024, we incurred approximately $5 million of expenses associated with the Hain Reimagined Program, compared to $10 million in the prior year

29

quarter. Annualized pretax savings are expected to be $130 million - $150 million. As part of the Hain Reimagined Program, the Company completed the sale of three non-core brands during the fourth quarter of fiscal 2024 and first quarter of fiscal 2025. We initiated actions to consolidate our personal care manufacturing footprint, which were substantially completed in the first quarter of fiscal 2025. The Company also initiated actions to: (i) simplify its distribution footprint in the U.S.; (ii) rationalize certain product categories for greater capacity utilization, cost reduction and margin expansion; (iii) reduce office space; and (iv) exit its non-strategic joint venture in India as part of the Focus and Fuel pillars of the Hain Reimagined Program.

Global Economic Environment

The duration and intensity of inflation fluctuations, the possibility of an impending recession, alterations in consumer shopping and consumption patterns, and shifts in geopolitical events, such as the ongoing Russia-Ukraine conflict, may lead to increased supply chain expenses, and other business impacts. We continually assess the nature and extent of these potential and evolving impacts on our business, consolidated operational results, liquidity, and capital resources.

Comparison of Three Months Ended September 30, 2024 to Three Months Ended September 30, 2023

Consolidated Results

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the three months ended September 30, 2024 and 2023 (dollars in thousands, other than per share amounts and percentages, which may not add due to rounding):

	Three Months Ended										Change in
	September 30, 2024					September 30, 2023					Dollars			Percentage
Net sales	$	394,596		100.0	%	$	425,029		100.0	%	$	(30,433	)		(7.2	)%
Cost of sales		312,986		79.3	%		341,086		80.3	%		(28,100	)		(8.2	)%
Gross profit		81,610		20.7	%		83,943		19.7	%		(2,333	)		(2.8	)%
Selling, general and administrative expenses		71,328		18.1	%		77,169		18.2	%		(5,841	)		(7.6	)%
Productivity and transformation costs		5,018		1.3	%		6,403		1.5	%		(1,385	)		(21.6	)%
Amortization of acquired intangible assets		2,180		0.6	%		1,955		0.5	%		225			11.5	%
Long-lived asset impairment		31		0.0	%		694		0.2	%		(663	)		(95.5	)%
Operating income (loss)		3,053		0.8	%		(2,278	)	(0.5	)%		5,331		*
Interest and other financing expense, net		13,746		3.5	%		13,244		3.1	%		502			3.8	%
Other expense (income), net		5,292		1.3	%		(265	)	(0.1	)%		5,557		*
Loss before income taxes and equity in net loss of equity-method investees		(15,985	)	(4.1	)%		(15,257	)	(3.6	)%		(728	)		4.8	%
Provision (benefit) for income taxes		3,523		0.9	%		(5,379	)	(1.3	)%		8,902		*
Equity in net loss of equity-method investees		155		0.0	%		498		0.1	%		(343	)		(68.9	)%
Net loss	$	(19,663	)	(5.0	)%	$	(10,376	)	(2.4	)%	$	(9,287	)		89.5	%
Adjusted EBITDA	$	22,375		5.7	%	$	24,090		5.7	%	$	(1,715	)		(7.1	)%
Diluted net loss per common share	$	(0.22	)			$	(0.12	)			$	(0.10	)		88.8	%

* Percentage is not meaningful due to one or more numbers being negative.

Net Sales

Net sales for the three months ended September 30, 2024 were $394.6 million, a decrease of $30.4 million, or 7.2%, including an unfavorable impact of $13.1 million or 2.9% related to divestitures, discontinued brands and exited product categories and a favorable impact of $3.3 million or 0.8% from foreign exchange, as compared to the prior year quarter. Organic net sales, defined as net sales adjusted to exclude the impact of foreign exchange, acquisitions, divestitures, discontinued brands and exited product categories, decreased $20.6 million, or 5.1%, from the prior year quarter. Additionally, the decrease in organic net sales was comprised of a 4% decrease in volume/mix and a 1% decrease in price. The decrease in each of net sales and organic net sales was primarily due to declines in both the North America and International reportable segments. Further details of changes in net sales by segment are provided below in the Segment Results section.

30

Gross Profit

Gross profit for the three months ended September 30, 2024 was $81.6 million, a decrease of $2.3 million, or 2.8%, as compared to the prior year quarter. However, gross profit margin of 20.7% for the three months ended September 30, 2024 was higher when compared with 19.7% in the prior year quarter.

The decrease in gross profit was driven primarily by the North America reportable segment, mainly due to lower sales volume, partially offset by favorable product mix and productivity improvements. The International reportable segment had an increase in gross profit mainly driven by higher margin due to productivity and improved promotional efficiency, partially offset by lower volume.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $71.3 million for the three months ended September 30, 2024, a decrease of $5.8 million, or 7.6%, from $77.2 million for the prior year quarter. The decrease was primarily due to lower marketing and advertising expense and employee-related expenses.

Productivity and Transformation Costs

Productivity and transformation costs were $5.0 million for the three months ended September 30, 2024, a decrease of $1.4 million, or 21.6%, from $6.4 million in the prior year quarter. The decrease was primarily due to lower restructuring costs incurred in connection with the Hain Reimagined Program.

Amortization of Acquired Intangible Assets

Amortization of acquired intangibles was $2.2 million for the three months ended September 30, 2024, an increase of $0.2 million from $2.0 million in the prior year quarter.

Long-Lived Asset Impairment

During the three months ended September 30, 2023, the Company recognized a non-cash impairment charge of $0.7 million related to certain equipment in North America.

Operating Income (Loss)

Operating income for the three months ended September 30, 2024 was $3.1 million compared to an operating loss of $2.3 million in the prior year quarter as a result of the items described above.

Interest and Other Financing Expense, Net

Interest and other financing expense, net totaled $13.7 million for the three months ended September 30, 2024, an increase of $0.5 million, or 3.8%, from $13.2 million in the prior year quarter. The increase resulted primarily from higher borrowing rates, partially offset by a lower outstanding debt balance compared to the prior year quarter. See Note 9, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Other Expense (Income), Net

Other expense, net totaled $5.3 million for the three months ended September 30, 2024, compared to $0.3 million of other income, net in the prior year quarter. The change primarily reflected the recognition of a $3.9 million pretax loss on the sale of the ParmCrisps® business in the first quarter of 2024 and higher net unrealized foreign currency losses.

Loss Before Income Taxes and Equity in Net Loss of Equity-Method Investees

Loss before income taxes and equity in net loss of our equity-method investees for the three months ended September 30, 2024 was $16.0 million compared to $15.3 million in the prior year quarter. The increase in the loss before income taxes and equity in net loss of our equity-method investees was due to the items discussed above.

31

Provision (Benefit) for Income Taxes

The provision (benefit) for income taxes includes federal, foreign, state and local income taxes. Our income tax expense was $3.5 million for the three months ended September 30, 2024 compared to benefit of $5.4 million in the prior year quarter.

The effective income tax rate was an expense of 22.0% and a benefit of 35.3% for the three months ended September 30, 2024 and 2023, respectively. The income tax expense for the three months ended September 30, 2024 reflected foreign tax expense in certain jurisdictions and an increase in the valuation allowance for both federal and state income taxes.

Equity in Net Loss of Equity-Method Investees

Equity in net loss from our equity-method investments for the three months ended September 30, 2024 was a loss of $0.2 million compared to a $0.5 million loss in the prior year quarter.

Net Loss

Net loss for the three months ended September 30, 2024 was $19.7 million, or $0.22 per diluted share, compared to $10.4 million, or $0.12 per diluted share, in the prior year quarter. The increase in net loss was attributable to the factors noted above.

Adjusted EBITDA

Adjusted EBITDA was $22.4 million and $24.1 million for the three months ended September 30, 2024 and 2023, respectively, as a result of the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation of our net loss to Adjusted EBITDA.

32

Segment Results

The following table provides a summary of net sales and Adjusted EBITDA by reportable segment for the three months ended September 30, 2024 and 2023:

(Dollars in thousands)	North America			International			Corporate and Other			Consolidated
Net sales
Three months ended 9/30/24	$	231,140		$	163,456		$	—		$	394,596
Three months ended 9/30/23		260,054			164,975			—			425,029
$ change	$	(28,914	)	$	(1,519	)	n/a			$	(30,433	)
% change		(11.1	)%		(0.9	)%	n/a				(7.2	)%
Adjusted EBITDA
Three months ended 9/30/24	$	12,459		$	20,370		$	(10,454	)	$	22,375
Three months ended 9/30/23		18,727			17,438			(12,075	)		24,090
$ change	$	(6,268	)	$	2,932		$	1,621		$	(1,715	)
% change		(33.5	)%		16.8	%		(13.4	)%		(7.1	)%
Adjusted EBITDA margin
Three months ended 9/30/24		5.4	%		12.5	%	n/a				5.7	%
Three months ended 9/30/23		7.2	%		10.6	%	n/a				5.7	%

See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations and Note 17, Segment Information, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q for a reconciliation of segment Adjusted EBITDA.

North America

Our net sales in the North America reportable segment for the three months ended September 30, 2024 were $231.1 million, a decrease of $28.9 million, or 11.1%, including an unfavorable impact of $12.9 million or 4.4% related to divestitures, discontinued brands and exited product categories, as compared to the prior year quarter. Organic net sales decreased $15.5 million, or 6.5% to $223.6 million from $239.1 million in the prior year quarter.

The decrease in each of net sales and organic net sales was primarily due to lower sales in the snacks category, as expected, due to the timing shift of a promotional event that was held in the first quarter of last fiscal year into the third quarter of the current fiscal year, as well as by a decline in the meal preparation category, partially offset by growth in the beverages category.

Adjusted EBITDA for the three months ended September 30, 2024 was $12.5 million, a decrease of $6.3 million, or 33.5%, from Adjusted EBITDA of $18.7 million in the prior year quarter. The decrease was primarily driven by lower volume and inflation, partially offset by productivity. Adjusted EBITDA margin was 5.4%, a 180-basis point decrease from the prior year period.

International

Our net sales in the International reportable segment for the three months ended September 30, 2024 were $163.5 million, a decrease of $1.5 million, or 0.9%, including a favorable impact of $3.9 million or 2.3% related to foreign exchange, as compared to the prior year quarter. Organic net sales decreased $5.1 million or 3.1% to $159.4 million from $164.5 million the prior year quarter.

The decrease in net sales was primarily due to lower sales in the beverages and baby & kids categories on account of lower branded sales. The decrease in organic net sales was primarily due to lower sales in the meal preparation and baby & kids categories. The decrease in the meal preparation category was due to short-term softness in private label spreads and drizzles, partially offset by strong soup performance across brands. Baby & kids category net sales were lower due to lower branded sales.

Adjusted EBITDA for the three months ended September 30, 2024 was $20.4 million, an increase of $2.9 million, or 16.8%, from Adjusted EBITDA of $17.4 million in the prior year quarter. The increase was primarily driven by an increase in gross

33

profit reflecting improved margin associated with productivity improvements and improved promotional efficiency, partially offset by lower volume and a decrease in selling, general and administrative expenses. Adjusted EBITDA margin was 12.5%, a 190-basis point increase from the prior year period.

Corporate and Other

The decrease in Corporate and Other expenses primarily reflected a decrease in consulting charges.

Refer to Note 17, Segment Information, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Liquidity and Capital Resources

We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Credit Agreement (as defined below). We believe that our cash flows from operations and borrowing capacity under our Credit Agreement will be adequate to meet anticipated operating and other expenditures for the foreseeable future. See Note 9, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

In addition to obligations under the Credit Agreement, we are party to other contractual obligations involving commitments to make payments to third parties, including purchase commitments and lease obligations, which impact our short-term and long-term liquidity and capital resource needs. See Note 7, Leases.

Amended and Restated Credit Agreement

On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement (as amended, the “Credit Agreement”). The Credit Agreement provides for senior secured financing of $1,100 million in the aggregate, consisting of (1) $300 million in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and is comprised of a $440 million U.S. revolving credit facility and $360 million global revolving credit facility) (the “Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026. The Company’s obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions.

The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio. Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023 and 5.00:1.00 until December 31, 2024 (the period of time during which such maximum consolidated secured leverage ratios are in effect, the “Second Amendment Period”). Following the Second Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00. Pursuant to the Second Amendment, the Company’s minimum interest coverage ratio was amended to be 2.50:1.00. As of September 30, 2024, the Company’s consolidated secured leverage ratio, consolidated leverage ratio and consolidated interest coverage ratio were 3.87:1.00, 3.87:1.00 and 3.26:1.00, respectively, and the Company was in compliance with all associated covenants. The aforementioned financial covenants are being reported as calculated under the Credit Agreement and not pursuant to U.S. GAAP. Please refer to the Credit Agreement filed as an exhibit to our periodic reports for further information related to the calculation thereof. For risks related to our indebtedness and compliance with these covenants, please refer to the risk factor “Any default under our credit agreement could have significant consequences” set forth in Part I, Item 1A of our most recent annual report on Form 10-K.

During the Second Amendment Period, loans under the Credit Agreement bear interest at (a) Term SOFR plus 2.5% per annum or (b) the Base Rate plus 1.5% per annum. Following the Second Amendment Period, loans bear interest at rates based on (a) Term SOFR plus a rate ranging from 1.125% to 2.0% per annum or (b) the Base Rate plus a rate ranging from 0.125% to 1.0% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Second Amendment

34

Period is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement as amended by the Second Amendment. Excluding the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2024 was 7.76%. During fiscal 2022, the Company used interest rate swaps to hedge a portion of the interest rate risk related its outstanding variable rate debt. As of September 30, 2024, the notional amount of the interest rate swaps was $400 million with fixed rate payments of 5.60%. Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2024 was 6.56%. Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

As of September 30, 2024, there were $473,000 of loans under the Revolver, $268,675 of Term Loans, and $3,247 of letters of credit outstanding under the Credit Agreement. As of September 30, 2024, $323,753 was available under the Credit Agreement, subject to compliance with the financial covenants. As of September 30, 2024, the Company was in compliance with all associated covenants.

Our cash and cash equivalents balance increased by $2.5 million at September 30, 2024 to $56.9 million as compared to $54.3 million at June 30, 2024. Our working capital was $283.3 million at September 30, 2024, an increase of $7.8 million from $275.6 million at the end of fiscal 2024. Additionally, our total debt decreased by $3.7 million at September 30, 2024 to $740.4 million as compared to $744.1 million at June 30, 2024 as a result of net repayments carried out during the period.

Our cash balances are held in the U.S., U.K., Canada, Western Europe, the Middle East and India. As of September 30, 2024, substantially all cash was held outside of the U.S.

We maintain our cash and cash equivalents primarily in money market funds or their equivalent. Accordingly, we do not believe that our investments have significant exposure to interest rate risk. Cash (used in) provided by operating, investing and financing activities is summarized below.

	Three Months Ended September 30,						Change in
(Dollars in thousands)	2024			2023			Dollars
Cash flows (used in) provided by:
Operating activities	$	(10,787	)	$	14,030		$	(24,817	)
Investing activities		6,309			(5,649	)		11,958
Financing activities		(4,198	)		(17,584	)		13,386
Effect of exchange rate changes on cash		11,222			(5,881	)		17,103
Net increase (decrease) in cash and cash equivalents	$	2,546		$	(15,084	)	$	17,630

Cash used in operating activities was $10.8 million for the three months ended September 30, 2024, a decrease of $24.8 million from cash provided by operating activities of $14.0 million in the prior year period. This increase in cash used in operating activities versus the prior year period resulted primarily from higher cash utilization of $28.9 million for our working capital accounts which was mainly due to lower accounts payable and accrued expenses of $22.8 million, primarily reflecting timing of payments to suppliers in North America and cash restructuring charges, partially offset by focused inventory management, which generated year-over-year improvement of $9.7 million as well as a reduction of $4.1 million in net loss adjusted for non-cash charges.

Cash provided by investing activities was $6.3 million for the three months ended September 30, 2024, an increase of $12.0 million from cash used in investing activities of $5.6 million in the prior year period primarily due to an increase in proceeds from asset sales of $10.8 million and lower capital expenditures in the current period due to phasing of capital projects. During the three months ended September 30, 2024, $5.8 million of capital expenditures were incurred primarily related to operational improvements in the United States and United Kingdom. We expect capital expenditures to be approximately $50 million for fiscal year 2025.

35

Cash used in financing activities was $4.2 million for the three months ended September 30, 2024, a decrease of $13.4 million compared to $17.6 million in the prior year period. The decrease in cash used in financing activities was primarily due to lower net debt repayment during the three months ended September 30, 2024.

Free Cash Flow

Our free cash flow was negative $16.5 million for the three months ended September 30, 2024, a decrease of $23.7 million from free cash flow of $7.1 million in the three months ended September 30, 2023. The period-over-period change resulted primarily from a decrease in cash flows from operations of $24.8 million driven by the reasons explained above, partially offset by lower capital expenditures. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net cash (used in) provided by operating activities to free cash flow.

Share Repurchase Program

In January 2022, the Company’s Board of Directors authorized the repurchase of up to $200.0 million of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current 2022 authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the three months ended September 30, 2024, the Company did not repurchase any shares under the repurchase program. As of September 30, 2024, the Company had $173.5 million of remaining authorization under the share repurchase program.

Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures

We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors.

For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believe the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S. GAAP measures should be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measures.

Organic Net Sales

As noted above, we define organic net sales as net sales excluding the impact of acquisitions, divestitures, discontinued brands and exited product categories and foreign exchange. To adjust organic net sales for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To adjust organic net sales for the impact of divestitures, discontinued brands and exited product categories, the net sales of a divested business, discontinued brand or exited product category are excluded from all periods. To adjust organic net sales for the impact of foreign exchange, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year.

36

A reconciliation between reported net sales and organic net sales is as follows:

(Dollars in thousands)	North America			International			Hain Consolidated
Net sales - Three months ended September 30, 2024	$	231,140		$	163,456		$	394,596
Less: Divestitures, discontinued brands and exited product categories		8,110			218			8,328
Less: Impact of foreign currency exchange		(529	)		3,835			3,306
Organic net sales - Three months ended September 30, 2024	$	223,559		$	159,403		$	382,962
Net sales - Three months ended September 30, 2023	$	260,054		$	164,975		$	425,029
Less: Divestitures, discontinued brands and exited product categories		20,973			476			21,449
Organic net sales - Three months ended September 30, 2023	$	239,081		$	164,499		$	403,580
Net sales decline		(11.1	)%		(0.9	)%		(7.2	)%
Less: Impact of divestitures, discontinued brands and exited product categories		(4.4	)%		(0.1	)%		(2.9	)%
Less: Impact of foreign currency exchange		(0.2	)%		2.3	%		0.8	%
Organic net sales decline		(6.5	)%		(3.1	)%		(5.1	)%

Adjusted EBITDA

The Company defines Adjusted EBITDA as net loss before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses, certain litigation expenses, net, plant closure related costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, loss on sale of assets, long-lived asset impairment and other adjustments. The Company’s management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the Company and as a component of performance-based executive compensation. Adjusted EBITDA is a non-U.S. GAAP measure and may not be comparable to similarly titled measures reported by other companies.

We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S. GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results.

37

A reconciliation of net loss to Adjusted EBITDA is as follows:

	Three Months Ended September 30,
(Dollars in thousands)	2024			2023
Net loss	$	(19,663	)	$	(10,376	)
Depreciation and amortization		11,427			12,305
Equity in net loss of equity-method investees		155			498
Interest expense, net		12,995			12,623
Provision (benefit) for income taxes		3,523			(5,379	)
Stock-based compensation, net		2,876			3,742
Unrealized currency losses		1,194			35
Certain litigation expenses, net(a)	827				1,524
Restructuring activities
Productivity and transformation costs		5,018			6,403
Plant closure related costs, net		376			1,841
Acquisitions, divestitures and other
Loss on sale of assets		3,934			62
Transaction and integration costs, net		(318	)		118
Impairment charges
Long-lived asset impairment		31			694
Adjusted EBITDA	$	22,375		$	24,090

(a) Expenses and items relating to securities class action and baby food litigation and SEC investigation.

Free Cash Flow

In our internal evaluations, we use the non-GAAP financial measure “Free Cash Flow.” The difference between Free Cash Flow and cash flows used in or provided by operating activities, which is the most comparable U.S. GAAP financial measure, is that Free Cash Flow reflects the impact of purchases of property, plant and equipment (capital spending). Since capital spending is essential to maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider capital spending when evaluating our cash flows provided by or used in operating activities. We view Free Cash Flow as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments. We do not consider Free Cash Flow in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP.

38

A reconciliation from cash flows (used in) provided by operating activities to Free Cash Flow is as follows:

	Three Months Ended September 30,
(Dollars in thousands)	2024			2023
Net cash (used in) provided by operating activities	$	(10,787	)	$	14,030
Purchases of property, plant and equipment		(5,757	)		(6,906	)
Free Cash Flow	$	(16,544	)	$	7,124

Critical Accounting Estimates

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. We believe in the quality and reasonableness of our critical accounting policies; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have applied. The accounting policies that have been identified as critical to our business operations and to understanding the results of our operations pertain to variable consideration, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation and valuation allowances for deferred tax assets. The application of each of these critical accounting policies and estimates is discussed in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, from which there have been no material changes. We are providing the below update regarding goodwill.

Goodwill

In each quarter subsequent to our annual impairment assessment, we review events that occur or circumstances that change, including the macroeconomic environment, our business performance and our market capitalization, to determine if a quantitative impairment assessment is necessary. If assumptions are not achieved or market conditions decline, potential impairment charges could result. Impairments to goodwill and other intangible assets may be caused by factors outside our control, such as increasing competitive pricing pressures, changes in discount rates based on changes in cost of capital (i.e., as a result of changes in interest rates or other conditions), lower than expected sales and profit growth rates, changes in industry EBITDA multiples, the inability to quickly replace lost co-manufacturing business, or the bankruptcy of a significant customer, among others.

As of September 30, 2024, we performed an assessment of factors to determine whether it was more likely than not that the fair value of our reporting units was less than its carrying amount, including goodwill. We concluded that were no events or circumstances that warranted an interim quantitative impairment test for goodwill during the three months ended September 30, 2024. As of September 30, 2024, goodwill associated with the U.S. reporting unit had a carrying value of $633,774. The U.S. reporting unit is at risk of impairment in the event of unfavorable changes in assumptions, including forecasted future cashflows based on execution of strategic initiatives for increasing revenue, as well as discount rates and other macroeconomic factors. We monitor our reporting units at risk of impairment for interim impairment indicators.

As of September 30, 2024, we considered our market capitalization and our net book value and performed a market capitalization reconciliation with the expectation that the market capitalization should reconcile within a reasonable range to the sum of the fair values of the Company's individual reporting units. Upon performing the market capitalization reconciliation, we noted a reasonable reconciliation between the sum of the reporting unit fair values and the Company’s market capitalization once adjusted for the impact of corporate costs not allocated to the reporting units. Refer to the critical accounting policies and estimates section included in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.

39

Recent Accounting Pronouncements

Refer to Note 2, Basis of Presentation, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Seasonality

Certain of our product lines have seasonal fluctuations. Hot tea, hot-eating desserts and soup sales are stronger in colder months, while sales of snack foods, sunscreen and certain of our personal care products are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. Historically, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes from the discussion of the material factors contained in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the SEC on August 27, 2024.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), with the assistance of other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on this review, our CEO and CFO have concluded that the disclosure controls and procedures for the Company were effective as of September 30, 2024.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting that occurred during the three months ended September 30, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

40

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

The information called for by this item is incorporated herein by reference to Note 16, Commitments and Contingencies, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Item 1A. Risk Factors

There have been no material changes from the discussion of the material factors contained in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the SEC on August 27, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

During the three months ended September 30, 2024, there were no shares repurchased under share repurchase programs approved by the Board of Directors.

During the three months ended September 30, 2024, there were 35,614 shares withheld by the Company to satisfy tax withholding obligations in connection with shares issued under stock-based compensation plans, at an average price of $8.47 per share. These shares withheld to satisfy tax withholding obligations do not constitute repurchases by the Company.

Item 5. Other Information

Rule 10b5-1 Trading Arrangements and Non-Rule 10b5-1 Trading Arrangements

During the three months ended September 30, 2024, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended), adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

41

Item 6. Exhibits

Exhibit Number	Description
3.1	Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021, filed with the SEC on August 26, 2021).
3.2	The Hain Celestial Group, Inc. Amended and Restated By-Laws (incorporated by reference to Exhibit 3.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, filed with the SEC on May 9, 2023).
4.1	Specimen of common stock certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the Company’s Registration Statement on Form S-4 filed with the SEC on April 24, 2000).
10.1*	First Amendment to The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 5, 2024).
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
32.1	Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Indicates management contract or compensatory plan or arrangement.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		THE HAIN CELESTIAL GROUP, INC.
		(Registrant)
Date:	November 7, 2024	/s/ Wendy P. Davidson
		Wendy P. Davidson, President and Chief Executive Officer (Principal Executive Officer)

Date:	November 7, 2024	/s/ Lee A. Boyce
		Lee A. Boyce, Chief Financial Officer (Principal Financial Officer)

Date:	November 7, 2024	/s/ Michael J. Ragusa
		Michael J. Ragusa, Senior Vice President and Chief Accounting Officer (Principal Accounting Officer)

43

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Wendy P. Davidson, certify that:

1.I have reviewed this quarterly report on Form 10-Q of The Hain Celestial Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 7, 2024

/s/ Wendy P. Davidson

Wendy P. Davidson

President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Lee A. Boyce, certify that:

1.I have reviewed this quarterly report on Form 10-Q of The Hain Celestial Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 7, 2024

/s/ Lee A. Boyce

Lee A. Boyce

Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION FURNISHED

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Wendy P. Davidson, President and Chief Executive Officer of The Hain Celestial Group, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:

•The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

•The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 7, 2024

/s/ Wendy P. Davidson

Wendy P. Davidson

President and Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION FURNISHED

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Lee A. Boyce, Executive Vice President and Chief Financial Officer of The Hain Celestial Group, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:

•The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

•The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 7, 2024

/s/ Lee A. Boyce

Lee A. Boyce

Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

XML

Cover Page - shares	3 Months Ended
	Sep. 30, 2024	Oct. 31, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	0-22818
Entity Registrant Name	THE HAIN CELESTIAL GROUP, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-3240619
Entity Address, Address Line One	221 River Street
Entity Address, City or Town	Hoboken
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07030
City Area Code	516
Local Phone Number	587-5000
Title of 12(b) Security	Common Stock, par value $.01 per share
Trading Symbol	HAIN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		90,194,130
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000910406
Current Fiscal Year End Date	--06-30

XML

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Current assets:
Cash and cash equivalents	$ 56,853	$ 54,307
Accounts receivable, less allowance for doubtful accounts of $1,511 and $1,517, respectively	188,190	179,190
Inventories	270,418	274,128
Prepaid expenses and other current assets	48,570	49,434
Total current assets	564,031	557,059
Property, plant and equipment, net	266,947	261,730
Goodwill	936,341	929,304
Trademarks and other intangible assets, net	250,179	244,799
Investments and joint ventures	10,080	10,228
Operating lease right-of-use assets, net	85,029	86,634
Other assets	22,202	27,794
Total assets	2,134,809	2,117,548
Current liabilities:
Accounts payable	184,969	188,220
Accrued expenses and other current liabilities	88,160	85,714
Current portion of long-term debt	7,567	7,569
Total current liabilities	280,696	281,503
Long-term debt, less current portion	732,799	736,523
Deferred income taxes	45,397	47,826
Operating lease liabilities, noncurrent portion	78,905	80,863
Other noncurrent liabilities	33,351	27,920
Total liabilities	1,171,148	1,174,635
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	0	0
Common stock - $.01 par value, authorized 150,000 shares; issued: 111,964 and 111,867 shares, respectively; outstanding: 89,907 and 89,846 shares, respectively	1,120	1,119
Additional paid-in capital	1,233,129	1,230,253
Retained earnings	557,856	577,519
Accumulated other comprehensive loss	(99,409)	(137,245)
Total stockholders' equity including treasury stock	1,692,696	1,671,646
Less: Treasury stock, at cost, 22,057 and 22,021 shares, respectively	(729,035)	(728,733)
Total stockholders’ equity	963,661	942,913
Total liabilities and stockholders’ equity	$ 2,134,809	$ 2,117,548

XML

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,511	$ 1,517
Preferred stock, par value (USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (shares)	5,000,000	5,000,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	150,000,000	150,000,000
Common stock, shares issued (shares)	111,964,000	111,867,000
Common stock, shares, outstanding (shares)	89,907,000	89,846,000
Treasury stock (shares)	22,057,000	22,021,000

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net sales	$ 394,596	$ 425,029
Cost of sales	312,986	341,086
Gross profit	81,610	83,943
Selling, general and administrative expenses	71,328	77,169
Productivity and transformation costs	5,018	6,403
Amortization of acquired intangible assets	2,180	1,955
Long-lived asset impairment	31	694
Operating income (loss)	3,053	(2,278)
Interest and other financing expense, net	13,746	13,244
Other expense (income), net	5,292	(265)
Loss before income taxes and equity in net loss of equity-method investees	(15,985)	(15,257)
Provision (benefit) for income taxes	3,523	(5,379)
Equity in net loss of equity-method investees	155	498
Net loss	$ (19,663)	$ (10,376)
Net loss per common share:
Basic (USD per share)	$ (0.22)	$ (0.12)
Diluted (USD per share)	$ (0.22)	$ (0.12)
Shares used in the calculation of net loss per common share:
Basic (shares)	89,861	89,512
Diluted (shares)	89,861	89,512

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (19,663)	$ (10,376)
Pretax amount
Foreign currency translation adjustments before reclassifications	47,815	(32,933)
Change in deferred (losses) gains on cash flow hedging instruments	(9,702)	3,238
Change in deferred gains (losses) on fair value hedging instruments	151	(381)
Change in deferred (losses) gains on net investment hedging instruments	(3,777)	1,821
Total other comprehensive income (loss)	34,487	(28,255)
Tax benefit (expense)
Foreign currency translation adjustments before reclassifications	0	0
Change in deferred (losses) gains on cash flow hedging instruments	2,438	(794)
Change in deferred gains (losses) on fair value hedging instruments	(38)	94
Change in deferred (losses) gains on net investment hedging instruments	949	(452)
Total other comprehensive income (loss)	3,349	(1,152)
After tax amount
Foreign currency translation adjustments before reclassifications	47,815	(32,933)
Change in deferred (losses) gains on cash flow hedging instruments	(7,264)	2,444
Change in deferred gains (losses) on fair value hedging instruments	113	(287)
Change in deferred (losses) gains on net investment hedging instruments	(2,828)	1,369
Total other comprehensive income (loss)	37,836	(29,407)
Total comprehensive income (loss)	$ 18,173	$ (39,783)

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss
Beginning balance (shares) at Jun. 30, 2023		111,339,000
Beginning balance at Jun. 30, 2023	$ 1,017,907	$ 1,113	$ 1,217,549	$ 652,561	$ (727,100)	$ (126,216)
Beginning balance (shares) at Jun. 30, 2023					21,864,000
Increase (Decrease) in Stockholders' Equity
Net loss	(10,376)			(10,376)
Other comprehensive income (loss)	(29,407)					(29,407)
Issuance of common stock pursuant to stock-based compensation plans (shares)		239,000
Issuance of common stock pursuant to stock-based compensation plans	3	$ 3
Employee shares withheld for taxes (shares)					86,000
Employee shares withheld for taxes	(875)				$ (875)
Stock-based compensation expense	3,742		3,742
Ending balance (shares) at Sep. 30, 2023		111,578,000
Ending balance at Sep. 30, 2023	$ 980,994	$ 1,116	1,221,291	642,185	$ (727,975)	(155,623)
Ending balance (shares) at Sep. 30, 2023					21,950,000
Beginning balance (shares) at Jun. 30, 2024	89,846,000	111,867,000
Beginning balance at Jun. 30, 2024	$ 942,913	$ 1,119	1,230,253	577,519	$ (728,733)	(137,245)
Beginning balance (shares) at Jun. 30, 2024	22,021,000				22,021,000
Increase (Decrease) in Stockholders' Equity
Net loss	$ (19,663)			(19,663)
Other comprehensive income (loss)	37,836					37,836
Issuance of common stock pursuant to stock-based compensation plans (shares)		97,000
Issuance of common stock pursuant to stock-based compensation plans	1	$ 1
Employee shares withheld for taxes (shares)					36,000
Employee shares withheld for taxes	(302)				$ (302)
Stock-based compensation expense	$ 2,876		2,876
Ending balance (shares) at Sep. 30, 2024	89,907,000	111,964,000
Ending balance at Sep. 30, 2024	$ 963,661	$ 1,120	$ 1,233,129	$ 557,856	$ (729,035)	$ (99,409)
Ending balance (shares) at Sep. 30, 2024	22,057,000				22,057,000

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01	$ 0.01

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (19,663)	$ (10,376)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	11,427	12,305
Deferred income taxes	(671)	(11,269)
Equity in net loss of equity-method investees	155	498
Stock-based compensation, net	2,876	3,742
Long-lived asset impairment	31	694
Loss on sale of assets	3,934	62
Other non-cash items, net	1,085	(556)
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable	(3,926)	(1,150)
Inventories	2,282	(7,423)
Other current assets	(2,471)	8,761
Other assets and liabilities	579	(3,198)
Accounts payable and accrued expenses	(6,425)	21,940
Net cash (used in) provided by operating activities	(10,787)	14,030
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(5,757)	(6,906)
Proceeds from sale of assets	12,066	1,257
Net cash provided by (used in) investing activities	6,309	(5,649)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	59,000	46,000
Repayments under bank revolving credit facility	(61,000)	(57,000)
Repayments under term loan	(1,875)	(1,875)
Payments of other debt, net	(21)	(3,834)
Employee shares withheld for taxes	(302)	(875)
Net cash used in financing activities	(4,198)	(17,584)
Effect of exchange rate changes on cash	11,222	(5,881)
Net increase (decrease) in cash and cash equivalents	2,546	(15,084)
Cash and cash equivalents at beginning of period	54,307	53,364
Cash and cash equivalents at end of period	$ 56,853	$ 38,280

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (19,663)	$ (10,376)

XML

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false

XML

Business

3 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business

1.BUSINESS

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”), was founded in 1993. Hain Celestial is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby & kids, beverages, meal preparation, and personal care are marketed and sold in over 70 countries around the world. The Company operates under two reportable segments: North America and International.

The Company’s leading brands include Garden Veggie Snacks™, Terra® chips, Garden of Eatin’® snacks, Hartley’s® Jelly, Earth’s Best® and Ella’s Kitchen® baby and kids foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, Greek Gods® yogurt, Cully & Sully®, Yorkshire Provender®, New Covent Garden® and Imagine® soups, Yves® and Linda McCartney’s® (under license) meat-free, and Avalon Organics® personal care, among others.

XML

Basis of Presentation

3 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Basis of Presentation

2. BASIS OF PRESENTATION

The Company’s unaudited consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net loss includes the Company's equity in the current earnings or losses of such companies.

The Company’s unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the “Form 10-K”). The amounts as of and for the periods ended June 30, 2024 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the three months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2025. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2024 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes.

All dollar amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousands, except par values and per share amounts, unless otherwise indicated.

Significant Accounting Policies

The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies.

Transfer of Financial Assets

The Company accounts for transfers of financial assets, such as non-recourse accounts receivable financing arrangements, when the Company has surrendered control over the related assets. Determining whether control has transferred requires an evaluation of relevant legal considerations, an assessment of the nature and extent of the Company’s continuing involvement with the assets transferred and any other relevant considerations. The Company has non-recourse financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivable in their entirety to the buyers and satisfied all of the conditions to report the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements was $56,959 and $86,506 during the three months ended September 30, 2024 and 2023, respectively. The incremental cost of financing receivables under these arrangements is included in selling, general and administrative expenses on the Company’s consolidated statements of operations. The proceeds from the sale of receivables are included in cash (used in) provided by operating activities on the consolidated statements of cash flows.

Recently Issued Accounting Pronouncements Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”. The amendments address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which will require entities to disclose more detailed information in the reconciliation of their statutory tax rate to their effective

tax rate. The ASU also requires entities to disclose more detailed information about income taxes paid, including by jurisdiction, pretax income (loss) from continuing operations, and income tax expense (benefit). The amendments are effective for fiscal years beginning after December 15, 2024 and for interim periods within fiscal years beginning after December 15, 2025. The amendments should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

XML

Loss Per Share

3 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Loss Per Share

3.LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share on the consolidated statements of operations:

	Three Months Ended September 30,
	2024			2023
Numerator:
Net loss	$	(19,663	)	$	(10,376	)
Denominator:
Basic and diluted weighted average shares outstanding		89,861			89,512
Basic and diluted net loss per common share	$	(0.22	)	$	(0.12	)

Due to the Company’s net loss in each of the three months ended September 30, 2024 and September 30, 2023, all common stock equivalents such as stock options, unvested restricted share units and performance share units have been excluded from the computation of diluted net loss per share. The effect of the stock options and unvested restricted share units would have been anti-dilutive to the computations. The performance share units were contingently issuable based on market conditions and such conditions had not been achieved during the respective periods.

XML

Disposition

3 Months Ended

Sep. 30, 2024

Discontinued Operations and Disposal Groups [Abstract]

Disposition

4.DISPOSITION

ParmCrisps®

On August 30, 2024, the Company completed the sale of its ParmCrisps® business for total cash consideration of $12,000, subject to customary post-closing adjustments. The divestiture is consistent with the Company’s portfolio simplification process. ParmCrisps® was part of the Company’s North America reportable segment. During the three months ended September 30, 2024, the Company deconsolidated the net assets of ParmCrisps®, primarily consisting of $7,280, $6,725, and $1,282 of goodwill, inventory, and machinery and equipment, respectively, and recognized a pretax loss on sale of $3,863 recorded in other expense (income), net.

XML

Inventories

3 Months Ended

Sep. 30, 2024

Inventory Disclosure [Abstract]

Inventories

5.INVENTORIES

Inventories consisted of the following:

	September 30, 2024		June 30, 2024
Finished goods	$	178,863	$	178,150
Raw materials, work-in-progress, and packaging		91,555		95,978
	$	270,418	$	274,128

XML

Property, Plant and Equipment, Net

3 Months Ended

Sep. 30, 2024

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment, Net

6.PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:

	September 30, 2024		June 30, 2024
Land	$	11,738	$	11,381
Buildings and improvements		59,381		57,030
Machinery and equipment		335,138		325,174
Computer hardware and software		54,940		54,139
Furniture and fixtures		21,830		20,943
Leasehold improvements		37,784		39,255
Construction in progress		11,534		12,783
		532,345		520,705
Less: Accumulated depreciation		265,398		258,975
	$	266,947	$	261,730

Depreciation expense for the three months ended September 30, 2024 and 2023 was $7,910 and $9,826, respectively.

XML

Leases

3 Months Ended

Sep. 30, 2024

Leases [Abstract]

Leases

7.LEASES

The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Western Europe. The Company determines if an arrangement is or contains a lease at inception. At September 30, 2024 and June 30, 2024, right of use assets related to finance leases are included in property, plant and equipment, net on the consolidated balance sheets. Lease liabilities for finance leases are included in the current and non-current portions of long-term debt on the consolidated balance sheets. Current portion of the operating lease liabilities are included in accrued expenses and other current liabilities on the consolidated balance sheets. The Company does not have any related party leases, and sublease transactions are de minimis.

The components of lease expenses for the three months ended September 30, 2024 and 2023 were as follows:

	Three Months Ended
	September 30, 2024		September 30, 2023
Operating lease expenses	$	4,109	$	4,578
Finance lease expenses		37		37
Variable lease expenses		173		182
Short-term lease expenses		426		395
Total lease expenses	$	4,745	$	5,192

XML

Goodwill and Other Intangible Assets

3 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

8.GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:

	North America			International		Total
Balance as of June 30, 2024(1)	$	689,468		$	239,836	$	929,304
Divestiture(2)		(7,280	)		—		(7,280	)
Translation		514			13,803		14,317
Balance as of September 30, 2024	$	682,702		$	253,639	$	936,341

(1)The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $7,700 is related to the North America reportable segment and $126,577 is related to the International reportable segment.

(2) During the three months ended September 30, 2024, the Company completed the divestiture of ParmCrisps®, a component of the North America reportable segment. Goodwill of $7,280 was assigned to the divested component on a relative fair value basis.

As of September 30, 2024, the Company performed an assessment of factors to determine whether it was more likely than not that the fair value of its reporting units was less than its carrying amount, including goodwill. The Company concluded that were no events or circumstances that warranted an interim quantitative impairment test for goodwill during the three months ended September 30, 2024. As of September 30, 2024, goodwill associated with the U.S. reporting unit had a carrying value of $633,774. The U.S. reporting unit is at risk of potential impairment if, among other things, the fair value of this reporting unit, and its associated assets, decreases in value due to the amount and timing of expected future cash flows, decreased customer demand for products, an inability to execute management’s business strategies, or general market conditions, such as economic downturns, and changes in interest rates, including discount rates. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company’s estimates. If the Company’s ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record impairment charges in future periods.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:

	September 30, 2024			June 30, 2024
Non-amortized intangible assets:
Trademarks and tradenames(1)	$	201,407		$	195,237
Amortized intangible assets:
Other intangibles		169,560			167,886
Less: Accumulated amortization		(120,788	)		(118,324	)
Net amortized intangible assets		48,772			49,562
Net other intangible assets	$	250,179		$	244,799

(1) The gross carrying value of trademarks and tradenames is reflected net of $251,551 of accumulated impairment charges as of September 30, 2024 and June 30, 2024.

There were no events or circumstances that warranted an interim impairment test for indefinite-lived intangible assets during the three months ended September 30, 2024 or 2023.

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships, trademarks and tradenames and are amortized over their estimated useful lives of 7 to 25 years. The weighted average remaining amortization period of amortized intangible assets is 8.7 years.

Amortization expense included in the consolidated statements of operations is as follows:

	Three Months Ended September 30,
	2024		2023
Amortization of acquired intangibles	$	2,180	$	1,955

XML

Debt and Borrowings

3 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Debt and Borrowings

9.DEBT AND BORROWINGS

Debt and borrowings consisted of the following:

	September 30, 2024			June 30, 2024
Revolving credit facility	$	473,000		$	475,000
Term loans		268,675			270,550
Less: Unamortized issuance costs		(1,510	)		(1,680	)
Other borrowings(1)		201			222
		740,366			744,092
Short-term borrowings and current portion of long-term debt(2)		7,567			7,569
Long-term debt, less current portion	$	732,799		$	736,523

(1) Includes $201 (June 30, 2024: $222) of finance lease obligations.

(2) Includes $83 (June 30, 2024: $85) of short-term finance lease obligations.

Amended and Restated Credit Agreement

On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement (as amended, the “Credit Agreement”). The Credit Agreement provides for senior secured financing of $1,100 million in the aggregate, consisting of (1) $300 million in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and is comprised of a $440 million U.S. revolving credit facility and $360 million global revolving credit facility) (the “Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026. The Company’s obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions.

The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio. Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023 and 5.00:1.00 until December 31, 2024 (the period of time during which such maximum consolidated secured leverage ratios are in effect, the “Second Amendment Period”). Following the Second Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00. Pursuant to the Second Amendment, the Company’s minimum interest coverage ratio was amended to be 2.50:1.00.

During the Second Amendment Period, loans under the Credit Agreement bear interest at (a) Term SOFR plus 2.5% per annum or (b) the Base Rate plus 1.5% per annum. Following the Second Amendment Period, loans bear interest at rates based on (a) Term SOFR plus a rate ranging from 1.125% to 2.0% per annum or (b) the Base Rate plus a rate ranging from 0.125% to 1.0% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Second Amendment

Period is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement as amended by the Second Amendment. Excluding the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2024 was 7.76%. During fiscal 2022, the Company used interest rate swaps to hedge a portion of the interest rate risk related its outstanding variable rate debt. As of September 30, 2024, the notional amount of the interest rate swaps was $400 million with fixed rate payments of 5.60%. Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2024 was 6.56%. Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

As of September 30, 2024, there were $473,000 of loans under the Revolver, $268,675 of Term Loans, and $3,247 of letters of credit outstanding under the Credit Agreement. As of September 30, 2024, $323,753 was available under the Credit Agreement, subject to compliance with the financial covenants. As of September 30, 2024, the Company was in compliance with all associated covenants.

Credit Agreement Issuance Costs

In connection with the First and Second Amendments to its Credit Agreement during the second quarter of fiscal year 2023 and first quarter of fiscal year 2024, respectively, the Company incurred debt issuance costs of approximately $5,841, of which $5,729 was deferred. Of the total deferred costs, $4,198 were associated with the Revolver and are being amortized on a straight-line basis within Other assets on the consolidated balance sheets, and $1,531 are being recorded as an adjustment to the carrying amount of the Term Loans as a component of Interest and other financing expense, net over the term of the Credit Agreement utilizing the effective interest rate method.

Interest paid during the three months ended September 30, 2024 and September 30, 2023 was $12,455 and $11,432, respectively.

XML

Income Taxes

3 Months Ended

Sep. 30, 2024

Income Tax Disclosure [Abstract]

Income Taxes

10.INCOME TAXES

In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. However, to the extent that application of the estimated annual effective tax rate is not representative of the quarterly portion of actual tax expense expected to be recorded for the year in a jurisdiction, the Company determines the provision for income taxes based on actual year-to-date income (loss), which has been the case for certain jurisdictions for the quarter ended September 30, 2024. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

The effective income tax rate was an expense of 22.0% and a benefit of 35.3% for the three months ended September 30, 2024 and 2023, respectively. The income tax expense for the three months ended September 30, 2024 reflected foreign tax expense in certain jurisdictions and an increase in the valuation allowance for both federal and state income taxes.

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Sep. 30, 2024

Equity [Abstract]

Accumulated Other Comprehensive Loss

11.ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table presents the changes in accumulated other comprehensive loss (“AOCL”):

	Foreign Currency Translation Adjustment, Net			Deferred Gains (Losses) on Cash Flow Hedging Instruments, Net			Deferred Gains (Losses) on Fair Value Hedging Instruments, Net			Deferred Gains (Losses) on Net Investment Hedging Instruments, Net			Total
Balance at June 30, 2023	$	(138,028	)	$	10,898		$	685		$	229		$	(126,216	)
Other comprehensive (loss) income before reclassifications		(32,933	)		4,159			430			1,741			(26,603	)
Amounts reclassified into income		—			(1,715	)		(717	)		(372	)		(2,804	)
Net change in accumulated other comprehensive (loss) income for the three months ended September 30, 2023(1)		(32,933	)		2,444			(287	)		1,369			(29,407	)
Balance at September 30, 2023	$	(170,961	)	$	13,342		$	398		$	1,598		$	(155,623	)
Balance at June 30, 2024	$	(147,073	)	$	9,395		$	297		$	136		$	(137,245	)
Other comprehensive income (loss) before reclassifications		47,815			(5,515	)		(606	)		(2,457	)		39,237
Amounts reclassified into (income) expense		—			(1,749	)		719			(371	)		(1,401	)
Net change in accumulated other comprehensive income (loss) for the three months ended September 30, 2024(1)		47,815			(7,264	)		113			(2,828	)		37,836
Balance at September 30, 2024	$	(99,258	)	$	2,131		$	410		$	(2,692	)	$	(99,409	)

(1) See Note 14, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains on hedging instruments recorded in the consolidated statements of operations during the three months ended September 30, 2024 and 2023.

XML

Stock-Based Compensation and Incentive Performance Plans

3 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation and Incentive Performance Plans

12.STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company maintains a shareholder-approved plan, The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (as amended, the “2022 Plan”), which was approved at the Company’s 2022 Annual Meeting of Shareholders held on November 17, 2022, and further amended at the Company’s 2024 Annual Meeting of Shareholders held on October 31, 2024. The 2022 Plan permits the Company to continue making equity-based and other incentive awards in a manner intended to properly incentivize its employees, directors, consultants and other service providers by aligning their interests with the interests of the Company’s shareholders. The 2022 Plan is administered by the Compensation and Talent Management Committee of the Company’s Board of Directors. The Company also historically granted shares under its Amended and Restated 2002 Long-Term Incentive and Stock Award Plan (the “2002 Plan”) and its 2019 Equity Inducement Award Program (the “2019 Inducement Program”). The 2022 Plan, the 2002 Plan and the 2019 Inducement Program are collectively referred to as the “Stock Award Plans”. The Company’s long term incentive program (“LTIP”) is described in Note 13, Stock-Based Compensation and Incentive Performance Plans, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Compensation cost and related income tax benefits recognized in the consolidated statements of operations for stock-based compensation plans were as follows:

	Three Months Ended September 30,
	2024		2023
Selling, general and administrative expense	$	2,876	$	3,742
Related income tax benefit	$	283	$	456

Stock-Based Award Activity

Stock-based awards are generally issued in the form of restricted share units (“RSU”), which are service-based awards, and performance share units (“PSU”) that are subject to the achievement of minimum market conditions. RSU awards to employees generally provide for vesting in equal annual installments over a period of three years, with different vesting periods in certain cases. RSU awards to non-employee directors generally provide for a vesting period of one year. For PSU awards, the following share figures are stated at target levels, and the awards outstanding as of September 30, 2024 generally provide for vesting at 0% to 200% of the target level. Awards of PSUs and RSUs are issued at no cost to the recipient. A summary of all stock-based award activity for the three months ended September 30, 2024 is as follows:

	Number of Shares and Units			Weighted Average Grant Date Fair Value (per share)
Non-vested RSUs and PSUs outstanding at June 30, 2024		2,165		$	15.03
Granted		12		$	7
Vested		(97	)	$	18.15
Forfeited		(69	)	$	15.14
Non-vested RSUs and PSUs outstanding at September 30, 2024		2,011		$	14.83

The fair value of RSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting was as follows:

	Three Months Ended September 30,
	2024		2023
Fair value of RSUs granted	$	86	$	—
Fair value of shares vested	$	823	$	2,422
Tax benefit recognized from restricted shares vesting	$	100	$	281

At September 30, 2024, there was $15,518 of unrecognized stock-based compensation expense related to non-vested restricted stock awards, which is expected to be recognized over a weighted average period of 1.8 years.

XML

Financial Instruments Measured At Fair Value

3 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Financial Instruments Measured At Fair Value

13.FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of September 30, 2024:

	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	$	5,397	$	—	$	5,397	$	—
Liabilities:
Derivative financial instruments	$	8,159		—	$	8,159		—

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:

	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	$	14,982	$	—	$	14,982	$	—
Liabilities:
Derivative financial instruments	$	3,333		—	$	3,333		—

There were no transfers of financial instruments between the three levels of fair value hierarchy during the three months ended September 30, 2024 or 2023.

Derivative Instruments

The Company uses interest rate swaps to manage interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage exposure to currency fluctuations. These instruments are valued using techniques like discounted cash flow analysis, which considers the contractual terms and market-based inputs such as interest rate curves and implied volatilities. The fair values of interest rate swaps are determined by netting the discounted future fixed and variable cash flows. The variable cash flows are based on expected future interest rates.

Credit valuation adjustments are made to reflect the nonperformance risk of both the Company and its counterparties. Most inputs used to value derivatives fall within Level 2 of the fair value hierarchy, but credit valuation adjustments use Level 3 inputs, such as current credit spreads. The impact of these adjustments was not significant to the overall valuation, so all derivatives as of September 30, 2024 and June 30, 2024 were classified as Level 2.

Nonrecurring Fair Value Measurements

The Company measures certain non-financial assets, such as goodwill, intangible assets, property and equipment, and right-of-use lease assets, at fair value on a nonrecurring basis. These assets are initially measured at fair value at the time of acquisition or purchase, with adjustments only for foreign currency translation. Periodically, these assets are tested for impairment by comparing their carrying values to their estimated fair values. If an asset is impaired, the Company recognizes an impairment expense equal to the excess of the carrying value over the estimated fair value.

For indefinite-lived intangible assets, the fair value is determined using the relief from royalty approach, considering factors like future growth, royalty rates, discount rates, and other variables. Fair value measurements for reporting units are estimated using discounted cash flow models, which involve significant management judgment and Level 3 inputs, such as economic conditions and customer demand. These measurements are performed at least annually for impairment testing. The Company bases its fair value estimates on reasonable assumptions but acknowledges their unpredictability and inherent uncertainty.

XML

Derivatives and Hedging Activities

3 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES AND HEDGING ACTIVITIES

14.DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposures to a wide variety of business and operational risks. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s receivables and borrowings.

Certain of the Company’s foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company’s cash receipts and payments in terms of the Company’s functional currency. The Company

enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. Dollar. Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During the three months ended September 30, 2024 and 2023, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate debt. During the next 12 months, the Company estimates that an additional $3,010 will be reclassified as a decrease to interest expense.

As of September 30, 2024, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

Interest Rate Derivative	Number of Instruments	Notional Amount
Interest rate swap	4	$	400,000

Cash Flow Hedges of Foreign Exchange Risk

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company, at times, uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange risks.

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the same period during which the hedged transaction affects earnings within the same income statement line item as the earnings effect of the hedged transaction. During the next 12 months, the Company estimates that no amount relating to the foreign currency forward contracts will be reclassified to interest expense. As of September 30, 2024, the Company had no outstanding foreign currency derivatives that were used to hedge its foreign exchange risks.

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Western Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency- fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in AOCL as part of the cumulative translation adjustment. Amounts are reclassified out of AOCL into earnings when the hedged net investment is either sold or substantially liquidated.

As of September 30, 2024, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

Foreign Currency Derivative	Number of Instruments	Notional Sold		Notional Purchased
Cross-currency swap	4	€	100,300	$	105,804

Fair Value Hedges

The Company is exposed to changes in the fair value of certain of its foreign denominated intercompany loans due to changes in foreign exchange spot rates. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in foreign exchange rates affecting gains and losses on intercompany loan principal and interest. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency-fixed-rate payments over the life of the agreement.

For derivatives designated and that qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in interest and other financing expense, net.

Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis, as documented at hedge inception in accordance with the Company’s accounting policy election. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction. During the next 12 months, the Company estimates that an additional $476 relating to cross currency swaps will be reclassified as a decrease to interest expense.

As of September 30, 2024, the Company had the following outstanding foreign currency derivatives that were used to hedge changes in fair value attributable to foreign exchange risk:

Foreign Currency Derivative	Number of Instruments	Notional Sold		Notional Purchased
Cross-currency swap	1	€	24,700	$	26,021

As of September 30, 2024 and June 30, 2024, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustment for fair value hedges:

	Carrying Amount of the Hedged Asset				Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset
	September 30, 2024		June 30, 2024		September 30, 2024		June 30, 2024
Intercompany loan receivable	$	27,548	$	26,465	$	1,083	$	(480	)

Designated Hedges

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheet as of September 30, 2024:

	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	3,008	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets		—	Other noncurrent liabilities		104
Cross-currency swaps	Prepaid expenses and other current assets		2,389	Accrued expenses and other current liabilities		—
Cross-currency swaps	Other noncurrent assets		—	Other noncurrent liabilities		8,055
Total derivatives designated as hedging instruments		$	5,397		$	8,159

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheet as of June 30, 2024:

	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	7,455	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets		5,151	Other noncurrent liabilities		—
Cross-currency swaps	Prepaid expenses and other current assets		2,376	Accrued expenses and other current liabilities		—
Cross-currency swaps	Other noncurrent assets		—	Other noncurrent liabilities		3,333
Total derivatives designated as hedging instruments		$	14,982		$	3,333

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL for the three months ended September 30, 2024 and 2023:

Derivatives in Cash Flow Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Reclassified from AOCL into Income	Amount of Gain Reclassified from AOCL into Income
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Interest rate swaps	$	(7,366	)	$	5,478	Interest and other financing expense, net	$	2,336	$	2,281
Foreign currency forward contracts		—			41	Cost of sales		—		—
	$	(7,366	)	$	5,519		$	2,336	$	2,281

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the consolidated statements of operations for the three months ended of September 30, 2024 and 2023:

	Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023
	Interest and other financing expense, net		Interest and other financing expense, net
The effects of cash flow hedging:
Gain on cash flow hedging relationships
Interest rate swaps
Amount of gain reclassified from AOCL into income	$	2,336	$	2,281

The following table presents the pre-tax effect of fair value hedge accounting on AOCL for the three months ended September 30, 2024 and 2023:

Derivatives in Fair value Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Cross-currency swaps	$	(809	)	$	572	Interest and other financing expense, net	$	123	$	123
	$	(809	)	$	572		$	123	$	123

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing fair value hedge accounting on the consolidated statements of operations as of September 30, 2024 and 2023:

	Location and Amount of (Loss) Gain Recognized in the Consolidated Statements of Operations on Fair Value Hedging Relationships
	Three Months Ended September 30, 2024			Three Months Ended September 30, 2023
	Interest and other financing expense, net			Interest and other financing expense, net
The effects of fair value hedging:
Gain on fair value hedging relationships
Cross-currency swaps
Amount of (loss) gain reclassified from AOCL into (expense) income	$	(960	)	$	953

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the consolidated statements of operations for the three months ended September 30, 2024 and 2023:

Derivatives in Net Investment Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Cross-currency swaps	$	(3,282	)	$	2,316	Interest and other financing expense, net	$	495	$	495

XML

Transformation Program - Hain Reimagined

3 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Transformation Program - Hain Reimagined

15.TRANSFORMATION PROGRAM - HAIN REIMAGINED

During the first quarter of fiscal year 2024, the Company initiated a multi-year growth, transformation and restructuring program (the “Hain Reimagined Program”). The Hain Reimagined Program is intended to optimize the Company’s portfolio, improve underlying profitability and increase its flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. The savings initiatives are expected to impact the Company’s reportable segments and Corporate and Other. Implementation of the Hain Reimagined Program is expected to be completed by the end of the 2027 fiscal year and is comprised of: contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses.

For the three months ended September 30, 2024, expenses associated with the Hain Reimagined Program in the amount of $5,018, $376, and $31, respectively, were recorded in productivity and transformation costs, cost of sales, and intangibles and long-lived asset impairment, respectively, on the consolidated statements of operations. For the three months ended September 30, 2023, expenses associated with the Hain Reimagined Program in the amount of $6,403 and $3,320, respectively, were recorded in productivity and transformation costs and cost of sales, respectively, on the consolidated statements of operations.

The table below sets forth expenses associated with the Hain Reimagined Program for the period ended September 30, 2024 and September 30, 2023 by reportable segments and Corporate and Other.

	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023
North America	$	2,241	$	3,358
Corporate and Other		1,990		5,770
International		1,194		595
	$	5,425	$	9,723

The following table displays the activities and liability balances relating to the Hain Reimagined Program for the period ended as of September 30, 2024. The Company expects to pay the remaining accrued restructuring costs during the next 12 months.

	Balance at June 30, 2024		Charges		Amounts Paid			Non-cash settlements/ Adjustments			Balance at September 30, 2024
Employee-related costs	$	1,985	$	2,280	$	(2,820	)	$	—		$	1,445
Contract termination costs		347		367		(8	)		(70	)		636
Asset write-downs1		—		31		—			(31	)		—
Other transformation-related expenses2		3,988		2,747		(2,454	)		(600	)		3,681
	$	6,320	$	5,425	$	(5,282	)	$	(701	)	$	5,762

1Represents non-cash asset write-downs including asset impairment and accelerated depreciation.
2Other transformation-related expenses primarily include consultancy charges related to reorganization of global functions and related personnel resource requirements, and rationalizing sourcing and supply chain processes.

XML

Commitments and Contingencies

3 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

16.COMMITMENTS AND CONTINGENCIES

Securities Class Actions Filed in Federal Court

On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York (the “District Court”) against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934: (1) Flora v. The Hain Celestial Group, Inc., et al.; (2) Lynn v. The Hain Celestial Group, Inc., et al.; and (3) Spadola v. The Hain Celestial Group, Inc., et al. (collectively, the “Securities Complaints”). The Securities Complaints were ultimately consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. During the summer of 2017, a Corrected Consolidated Amended Complaint was filed, which named as defendants the Company and certain of its former officers (collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and Securities and Exchange Commission (“SEC”) filings regarding the Company’s business, prospects, financial results and internal controls.

After Defendants’ initial motion to dismiss was granted without prejudice to replead in October 2017, the Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second Amended Complaint”). The Second Amended Complaint again named as defendants the Company and certain of its former officers and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations similar to those in the Corrected Consolidated Amended Complaint. Defendants filed a motion to dismiss the Second Amended Complaint on June 20, 2019. On April 6, 2020, the District Court granted Defendants’ motion to dismiss the Second Amended Complaint in its entirety, with prejudice. Co-Lead Plaintiffs appealed the District Court’s decision dismissing the Second Amended Complaint to the United States Court of Appeals for the Second Circuit (the “Second Circuit”). By decision dated December 17, 2021, the Second Circuit vacated the District Court’s judgment and remanded the case for further proceedings. The parties ultimately submitted supplemental briefing between May 12, 2022 and June 23, 2022, and in June 2022, the District Court referred Defendants’ Motion to Dismiss the Second Amended Complaint to a United States Magistrate Judge (the “Magistrate Judge”) for a Report and Recommendation. On November 4, 2022, the Magistrate Judge issued a Report and Recommendation recommending that the District Court grant Defendants’ Motion to Dismiss the Second Amended Complaint with prejudice. On September 29, 2023, the District Court granted Defendants’ Motion to Dismiss the Second Amended Complaint. Co-Lead Plaintiffs filed notice of appeal on October 26, 2023, appealing the District Court’s decision dismissing the Second Amended Complaint to the Second Circuit. Co-Lead Plaintiffs filed their opening brief on February 12, 2024. Defendants opposed, and the appeal was fully briefed as of June 3, 2024. The Court has scheduled oral argument on Plaintiffs’ appeal for December 5, 2024.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

The former Board of Directors and certain former officers of the Company are defendants in a consolidated action originally filed in 2017 in the Eastern District of New York under the captions Silva v. Simon, et al., Barnes v. Simon, et al., Merenstein v. Heyer, et al., and Oliver v. Berke, et al. Plaintiffs in the consolidated action, In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”), allege the violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment. The plaintiffs alleged in their Amended Complaint that the Company’s former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results and that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste.

On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to dismiss the Amended Complaint in the Consolidated Securities Action, described above. After the District Court granted Defendants’ motion to dismiss the Consolidated Securities Action, the Co-Lead Plaintiffs in that action filed a Second Amended Complaint on May 6, 2019. The

parties to the Consolidated Stockholder Class and Derivative Action thereby agreed to continue the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through 30 days after a decision on Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action.

On April 6, 2020, the District Court granted Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action, with prejudice. Pursuant to the terms of an agreed-upon stay, Defendants in the Consolidated Stockholder Class and Derivative Action had until May 6, 2020 to answer, move, or otherwise respond to the complaint in this matter. This deadline was extended, and Defendants moved to dismiss the Consolidated Stockholder Class and Derivative Action Complaint on June 23, 2020, with Plaintiffs’ opposition due August 7, 2020.

On July 24, 2020, Plaintiffs made a stockholder litigation demand on the current Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On November 3, 2020, Plaintiffs were informed that the Board of Directors had finished investigating and resolved, among other things, that the demand should be rejected. In light of the Second Circuit vacating the District Court’s judgment in the Consolidated Securities Action referenced above and remanding the case for further proceedings, the Parties submitted a joint status report on December 29, 2021 requesting that the District Court continue the temporary stay pending the District Court’s reconsideration of the Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action. The parties have most recently agreed to extend the stay through the earlier of November 8, 2024 or 30 days after the Second Circuit issues a decision on Plaintiffs’ currently pending appeal.

Baby Food Litigation

Since February 2021, the Company has been named in numerous consumer class actions alleging that the Company’s Earth’s Best® baby food products (the “Products”) contain unsafe and undisclosed levels of various naturally occurring heavy metals, namely lead, arsenic, cadmium and mercury. Those actions have now been transferred and consolidated as a single lawsuit in the U.S. District Court for the Eastern District of New York captioned In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678 (the “Consolidated Proceeding”), which generally alleges that the Company violated various state consumer protection laws and asserts other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals, arguing that consumers would have either not purchased the Products or would have paid less for them had the Company made adequate disclosures. The Company filed a motion to dismiss the Consolidated Class Action Complaint on November 7, 2022, which was opposed by the plaintiffs. On May 9, 2023, upon consent of the parties, the Court stayed the Consolidated Proceeding pending the Second Circuit’s decision on appeal in In re Beech-Nut Nutrition Co. Baby Food Litigation, 21 Civ. 133 (N.D.N.Y.) (the “Beech-Nut Case”). Accordingly, the Court denied the Company’s motion to dismiss without prejudice to renew.

By summary order dated January 18, 2024, the Second Circuit vacated the judgment dismissing the Beech-Nut Case and remanded for further proceedings. On February 15, 2024, the Company served a renewed motion to dismiss the Consolidated Proceeding. Plaintiffs served their opposition on March 14, 2024, and the Company served its reply on April 4, 2024. The Court heard oral argument on the motion to dismiss on August 1, 2024, and took the motion under submission. One consumer class action is pending in New York Supreme Court, Nassau County, which the court has stayed in deference to the Consolidated Proceeding. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled.

The claims raised in these lawsuits were brought in the wake of a highly publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the “House Report”), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publication of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and has provided documents and other requested information.

The Company has been named in one civil government enforcement action, State of New Mexico ex rel. Balderas v. Nurture, Inc., et al., which was filed by the New Mexico Attorney General against the Company and several other manufacturers based on the alleged presence of heavy metals in their baby food products. The Company and several other manufacturers moved to dismiss the New Mexico Attorney General’s lawsuit, and the Court denied that motion. The Company filed its answer to the New

Mexico Attorney General’s amended complaint on April 23, 2022, and discovery is set to commence. The Company denies the New Mexico Attorney General’s allegations and maintains that its baby foods are safe, properly labeled, and compliant with New Mexico law.

In addition to the consumer class actions discussed above, the Company is currently named in numerous lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company’s Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. These lawsuits generally allege injuries related to neurological development disorders such as autism and attention deficit hyperactivity disorder.

Multidistrict Litigation

•On January 4, 2024, Plaintiffs in federal cases across the country filed a Motion to Transfer Actions Pursuant to 28 U.S.C. § 1407 for Coordinated or Consolidated Pretrial Proceedings. On April 11, 2024, the United States Judicial Panel on Multidistrict Litigation granted Plaintiffs’ Motion and transferred the cases to the Northern District of California for coordinated or consolidated pretrial proceedings. In Re: Baby Food Products Liability Litigation (MDL No. 3101) has been assigned to District Judge Jacqueline Scott Corley. On April 15, 2024, Judge Corley issued Pretrial Order No. 1 staying all outstanding discovery proceedings and pending motions and vacating all previously scheduled hearing dates. There are approximately 24 federal cases filed against the Company pending in the multi-district litigation (“MDL”). Plaintiffs filed their Master Complaint on July 15, 2024. The MDL will first proceed with general causation discovery.

California State Court Cases

•There are currently seven cases against the Company pending in California state court, including six in Los Angeles Superior Court and one in Alameda Superior Court. The Plaintiffs filed a Petition for Coordination to the Chair of the Judicial Council seeking to coordinate the Alameda Superior Court and Los Angeles Superior Court cases. The Judicial Council granted the JCCP petition and on June 4, 2024, Judge Lawrence P. Riff (Los Angeles Superior Court) was assigned as trial coordination judge. All but one of the cases have been stayed.

•In one of the Los Angeles cases, Landon R. v. The Hain Celestial Group, Inc., et al., No. 23STCV24844, fact discovery has closed, and expert discovery is ongoing. The Court vacated the original January 2025 trial date, and a new trial date has not been set.

Other Cases

•In the matter Palmquist v. The Hain Celestial Group, Inc., a jury trial commenced on February 6, 2023 in the United States District Court for the Southern District of Texas. The Company moved for Directed Verdict at the close of Plaintiffs’ case. The Court granted the Company’s motion, finding no liability for the Company. The Court entered Final Judgment in the Company’s favor on March 3, 2023. On April 3, 2023, Plaintiffs filed their Notice of Appeal in the Fifth Circuit. Plaintiffs appealed, and on May 28, 2024, the Fifth Circuit reversed the district court’s order denying Plaintiff’s motion to remand the case and vacated the final judgement of the district court. the Company filed a petition for en banc reconsideration, which the Fifth Circuit denied. The case has been remanded to Texas state court. The Company expects to petition the Supreme Court of the United States for a writ of certiorari.

•In NC v. The Hain Celestial Group, et al., in the Superior Court for the State of California, County of Los Angeles, judgment was entered on October 26, 2023 in favor of the defendants as a result of successful defense pretrial motions, including the Company’s motion for summary judgment. The time for appeal has passed.

The Company denies that its Products led to any of the alleged injuries and will defend these cases vigorously. That said, as is common in circumstances of this nature, additional lawsuits may be filed against the Company in the future, asserting similar or different legal theories and seeking similar or different types of damages and relief. Such lawsuits may be resolved in a manner adverse to us, and we may incur substantial costs or damages not covered by insurance, which could have a material adverse effect on our financial condition and business.

SEC Investigation

In November 2023, the staff of the SEC informed the Company it was conducting an investigation relating to Hain Celestial and requested documents primarily concerning (i) the Company’s acquisition of one business and disposition of another business and certain related accounting matters and (ii) trading activity and other matters related to the Company’s earnings guidance in certain previous fiscal years. The Company is cooperating with the SEC in this investigation.

Other

In addition to the matters described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business.

With respect to all litigation and related matters, the Company records a liability when the Company believes it is probable that a liability has been incurred and the amount can be reasonably estimated. As of the end of the period covered by this report, the Company has not recorded a liability for any of the matters disclosed in this note. It is possible that some matters could require the Company to pay damages, incur other costs or establish accruals in amounts that could not be reasonably estimated as of the end of the period covered by this report.

XML

Segment Information

3 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Segment Information

17.SEGMENT INFORMATION

The Company’s organizational structure consists of two geographic based reportable segments: North America and International, which are also the operating segments. This structure is in line with how the Company’s Chief Operating Decision Maker (“CODM”) assesses the Company’s performance and allocates resources. The Company uses segment net sales and segment Adjusted EBITDA in order to analyze segment results and trends.

Segment Adjusted EBITDA excludes net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses, certain litigation and related costs, plant closure related costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, loss on sale of assets, long-lived asset impairments and other adjustments. In addition, Segment Adjusted EBITDA does not include Corporate and Other expenses related to the Company’s centralized administrative functions, which do not specifically relate to a reportable segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to the entire enterprise, litigation expense and expenses for certain professional fees, facilities, and other items which benefit the Company as a whole.

The following tables set forth financial information about each of the Company’s reportable segments. Information about total assets by segment is not disclosed because such information is not reported to or used by the Company’s CODM for purposes of assessing segment performance or allocating resources. Transactions between reportable segments were insignificant for all periods presented.

	Three Months Ended September 30,
	2024			2023
Net Sales:
North America	$	231,140		$	260,054
International		163,456			164,975
	$	394,596		$	425,029
Adjusted EBITDA:
North America	$	12,459		$	18,727
International		20,370			17,438
Total Reportable Segments Adjusted EBITDA		32,829			36,165
Corporate and Other		(10,454	)		(12,075	)
		22,375			24,090
Depreciation and amortization		(11,427	)		(12,305	)
Equity in net loss of equity-method investees		(155	)		(498	)
Interest expense, net		(12,995	)		(12,623	)
(Provision) benefit for income taxes		(3,523	)		5,379
Stock-based compensation, net		(2,876	)		(3,742	)
Unrealized currency losses		(1,194	)		(35	)
Certain litigation expenses, net(a)		(827	)		(1,524	)
Restructuring activities
Productivity and transformation costs		(5,018	)		(6,403	)
Plant closure related costs, net		(376	)		(1,841	)
Acquisitions, divestitures and other
Loss on sale of assets		(3,934	)		(62	)
Transaction and integration costs, net		318			(118	)
Impairment charges
Long-lived asset impairment		(31	)		(694	)
Net loss	$	(19,663	)	$	(10,376	)

(a) Expenses and items relating to securities class action, baby food litigation and SEC investigation.

The Company’s net sales by product category are as follows:

	Three Months Ended September 30,
	2024		2023
Snacks	$	99,475	$	117,088
Baby & Kids		60,768		62,528
Beverages		56,676		56,148
Meal preparation		159,392		165,196
Personal care		18,285		24,069
	$	394,596	$	425,029

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, are as follows:

	Three Months Ended September 30,
	2024		2023
United States	$	202,773	$	230,659
United Kingdom		122,406		121,051
Western Europe		41,050		43,924
Canada		28,367		29,395
	$	394,596	$	425,029

There has been no material change to Company’s total assets by segment from the amount disclosed in the Form 10-K for the fiscal year ended June 30, 2024.

XML

Basis of Presentation (Policies)

3 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Basis of Presentation

BASIS OF PRESENTATION

The Company’s unaudited consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net loss includes the Company's equity in the current earnings or losses of such companies.

The Company’s unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the “Form 10-K”). The amounts as of and for the periods ended June 30, 2024 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the three months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2025. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2024 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes.

All dollar amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousands, except par values and per share amounts, unless otherwise indicated.

Significant Accounting Policies

Significant Accounting Policies

The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies.

Transfer of Financial Assets

Transfer of Financial Assets

The Company accounts for transfers of financial assets, such as non-recourse accounts receivable financing arrangements, when the Company has surrendered control over the related assets. Determining whether control has transferred requires an evaluation of relevant legal considerations, an assessment of the nature and extent of the Company’s continuing involvement with the assets transferred and any other relevant considerations. The Company has non-recourse financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivable in their entirety to the buyers and satisfied all of the conditions to report the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements was $56,959 and $86,506 during the three months ended September 30, 2024 and 2023, respectively. The incremental cost of financing receivables under these arrangements is included in selling, general and administrative expenses on the Company’s consolidated statements of operations. The proceeds from the sale of receivables are included in cash (used in) provided by operating activities on the consolidated statements of cash flows.

Recently Issued Accounting Pronouncements Not Yet Adopted

Recently Issued Accounting Pronouncements Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”. The amendments address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which will require entities to disclose more detailed information in the reconciliation of their statutory tax rate to their effective

tax rate. The ASU also requires entities to disclose more detailed information about income taxes paid, including by jurisdiction, pretax income (loss) from continuing operations, and income tax expense (benefit). The amendments are effective for fiscal years beginning after December 15, 2024 and for interim periods within fiscal years beginning after December 15, 2025. The amendments should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures,” which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

Financial instruments measured at fair value

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Derivative Instruments

The Company uses interest rate swaps to manage interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage exposure to currency fluctuations. These instruments are valued using techniques like discounted cash flow analysis, which considers the contractual terms and market-based inputs such as interest rate curves and implied volatilities. The fair values of interest rate swaps are determined by netting the discounted future fixed and variable cash flows. The variable cash flows are based on expected future interest rates.

Credit valuation adjustments are made to reflect the nonperformance risk of both the Company and its counterparties. Most inputs used to value derivatives fall within Level 2 of the fair value hierarchy, but credit valuation adjustments use Level 3 inputs, such as current credit spreads. The impact of these adjustments was not significant to the overall valuation, so all derivatives as of September 30, 2024 and June 30, 2024 were classified as Level 2.

Nonrecurring Fair Value Measurements

The Company measures certain non-financial assets, such as goodwill, intangible assets, property and equipment, and right-of-use lease assets, at fair value on a nonrecurring basis. These assets are initially measured at fair value at the time of acquisition or purchase, with adjustments only for foreign currency translation. Periodically, these assets are tested for impairment by comparing their carrying values to their estimated fair values. If an asset is impaired, the Company recognizes an impairment expense equal to the excess of the carrying value over the estimated fair value.

For indefinite-lived intangible assets, the fair value is determined using the relief from royalty approach, considering factors like future growth, royalty rates, discount rates, and other variables. Fair value measurements for reporting units are estimated using discounted cash flow models, which involve significant management judgment and Level 3 inputs, such as economic conditions and customer demand. These measurements are performed at least annually for impairment testing. The Company bases its fair value estimates on reasonable assumptions but acknowledges their unpredictability and inherent uncertainty.

XML

Loss Per Share (Tables)

3 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share on the consolidated statements of operations:

	Three Months Ended September 30,
	2024			2023
Numerator:
Net loss	$	(19,663	)	$	(10,376	)
Denominator:
Basic and diluted weighted average shares outstanding		89,861			89,512
Basic and diluted net loss per common share	$	(0.22	)	$	(0.12	)

XML

Inventories (Tables)

3 Months Ended

Sep. 30, 2024

Inventory Disclosure [Abstract]

Schedule of Components of Inventories

Inventories consisted of the following:

	September 30, 2024		June 30, 2024
Finished goods	$	178,863	$	178,150
Raw materials, work-in-progress, and packaging		91,555		95,978
	$	270,418	$	274,128

XML

Property, Plant and Equipment, Net (Tables)

3 Months Ended

Sep. 30, 2024

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment, Net

Property, plant and equipment, net consisted of the following:

	September 30, 2024		June 30, 2024
Land	$	11,738	$	11,381
Buildings and improvements		59,381		57,030
Machinery and equipment		335,138		325,174
Computer hardware and software		54,940		54,139
Furniture and fixtures		21,830		20,943
Leasehold improvements		37,784		39,255
Construction in progress		11,534		12,783
		532,345		520,705
Less: Accumulated depreciation		265,398		258,975
	$	266,947	$	261,730

XML

Leases (Tables)

3 Months Ended

Sep. 30, 2024

Leases [Abstract]

Schedule of Lease Expenses and Other Information

The components of lease expenses for the three months ended September 30, 2024 and 2023 were as follows:

	Three Months Ended
	September 30, 2024		September 30, 2023
Operating lease expenses	$	4,109	$	4,578
Finance lease expenses		37		37
Variable lease expenses		173		182
Short-term lease expenses		426		395
Total lease expenses	$	4,745	$	5,192

XML

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Changes In Carrying Amount Of Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:

	North America			International		Total
Balance as of June 30, 2024(1)	$	689,468		$	239,836	$	929,304
Divestiture(2)		(7,280	)		—		(7,280	)
Translation		514			13,803		14,317
Balance as of September 30, 2024	$	682,702		$	253,639	$	936,341

(1)The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $7,700 is related to the North America reportable segment and $126,577 is related to the International reportable segment.

(2) During the three months ended September 30, 2024, the Company completed the divestiture of ParmCrisps®, a component of the North America reportable segment. Goodwill of $7,280 was assigned to the divested component on a relative fair value basis.

Schedule of Finite-Lived Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:

	September 30, 2024			June 30, 2024
Non-amortized intangible assets:
Trademarks and tradenames(1)	$	201,407		$	195,237
Amortized intangible assets:
Other intangibles		169,560			167,886
Less: Accumulated amortization		(120,788	)		(118,324	)
Net amortized intangible assets		48,772			49,562
Net other intangible assets	$	250,179		$	244,799

(1) The gross carrying value of trademarks and tradenames is reflected net of $251,551 of accumulated impairment charges as of September 30, 2024 and June 30, 2024.

Schedule of Finite-lived Intangible Assets Amortization Expense

Amortization expense included in the consolidated statements of operations is as follows:

	Three Months Ended September 30,
	2024		2023
Amortization of acquired intangibles	$	2,180	$	1,955

XML

Debt and Borrowings (Tables)

3 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Summary of Debt and Borrowings

Debt and borrowings consisted of the following:

	September 30, 2024			June 30, 2024
Revolving credit facility	$	473,000		$	475,000
Term loans		268,675			270,550
Less: Unamortized issuance costs		(1,510	)		(1,680	)
Other borrowings(1)		201			222
		740,366			744,092
Short-term borrowings and current portion of long-term debt(2)		7,567			7,569
Long-term debt, less current portion	$	732,799		$	736,523

(1) Includes $201 (June 30, 2024: $222) of finance lease obligations.

(2) Includes $83 (June 30, 2024: $85) of short-term finance lease obligations.

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Sep. 30, 2024

Equity [Abstract]

Summary of Changes in Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in accumulated other comprehensive loss (“AOCL”):

	Foreign Currency Translation Adjustment, Net			Deferred Gains (Losses) on Cash Flow Hedging Instruments, Net			Deferred Gains (Losses) on Fair Value Hedging Instruments, Net			Deferred Gains (Losses) on Net Investment Hedging Instruments, Net			Total
Balance at June 30, 2023	$	(138,028	)	$	10,898		$	685		$	229		$	(126,216	)
Other comprehensive (loss) income before reclassifications		(32,933	)		4,159			430			1,741			(26,603	)
Amounts reclassified into income		—			(1,715	)		(717	)		(372	)		(2,804	)
Net change in accumulated other comprehensive (loss) income for the three months ended September 30, 2023(1)		(32,933	)		2,444			(287	)		1,369			(29,407	)
Balance at September 30, 2023	$	(170,961	)	$	13,342		$	398		$	1,598		$	(155,623	)
Balance at June 30, 2024	$	(147,073	)	$	9,395		$	297		$	136		$	(137,245	)
Other comprehensive income (loss) before reclassifications		47,815			(5,515	)		(606	)		(2,457	)		39,237
Amounts reclassified into (income) expense		—			(1,749	)		719			(371	)		(1,401	)
Net change in accumulated other comprehensive income (loss) for the three months ended September 30, 2024(1)		47,815			(7,264	)		113			(2,828	)		37,836
Balance at September 30, 2024	$	(99,258	)	$	2,131		$	410		$	(2,692	)	$	(99,409	)

(1) See Note 14, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains on hedging instruments recorded in the consolidated statements of operations during the three months ended September 30, 2024 and 2023.

XML

Stock-Based Compensation and Incentive Performance Plans (Tables)

3 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Compensation Cost and Related Income Tax Benefits Recognized

Compensation cost and related income tax benefits recognized in the consolidated statements of operations for stock-based compensation plans were as follows:

	Three Months Ended September 30,
	2024		2023
Selling, general and administrative expense	$	2,876	$	3,742
Related income tax benefit	$	283	$	456

Schedule of All Stock-Based Award Activity

A summary of all stock-based award activity for the three months ended September 30, 2024 is as follows:

	Number of Shares and Units			Weighted Average Grant Date Fair Value (per share)
Non-vested RSUs and PSUs outstanding at June 30, 2024		2,165		$	15.03
Granted		12		$	7
Vested		(97	)	$	18.15
Forfeited		(69	)	$	15.14
Non-vested RSUs and PSUs outstanding at September 30, 2024		2,011		$	14.83

Schedule of Restricted Stock Grant Information

The fair value of RSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting was as follows:

	Three Months Ended September 30,
	2024		2023
Fair value of RSUs granted	$	86	$	—
Fair value of shares vested	$	823	$	2,422
Tax benefit recognized from restricted shares vesting	$	100	$	281

XML

Financial Instruments Measured At Fair Value (Tables)

3 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis

The following table presents assets and liabilities measured at fair value on a recurring basis as of September 30, 2024:

	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	$	5,397	$	—	$	5,397	$	—
Liabilities:
Derivative financial instruments	$	8,159		—	$	8,159		—

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:

	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	$	14,982	$	—	$	14,982	$	—
Liabilities:
Derivative financial instruments	$	3,333		—	$	3,333		—

XML

Derivatives and Hedging Activities (Tables)

3 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

As of September 30, 2024, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

Interest Rate Derivative	Number of Instruments	Notional Amount
Interest rate swap	4	$	400,000

As of September 30, 2024, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

Foreign Currency Derivative	Number of Instruments	Notional Sold		Notional Purchased
Cross-currency swap	4	€	100,300	$	105,804

As of September 30, 2024, the Company had the following outstanding foreign currency derivatives that were used to hedge changes in fair value attributable to foreign exchange risk:

Foreign Currency Derivative	Number of Instruments	Notional Sold		Notional Purchased
Cross-currency swap	1	€	24,700	$	26,021

As of September 30, 2024 and June 30, 2024, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustment for fair value hedges:

	Carrying Amount of the Hedged Asset				Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset
	September 30, 2024		June 30, 2024		September 30, 2024		June 30, 2024
Intercompany loan receivable	$	27,548	$	26,465	$	1,083	$	(480	)

Schedule of Derivative Financial Instruments and Classification on Consolidated Balance Sheets

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheet as of September 30, 2024:

	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	3,008	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets		—	Other noncurrent liabilities		104
Cross-currency swaps	Prepaid expenses and other current assets		2,389	Accrued expenses and other current liabilities		—
Cross-currency swaps	Other noncurrent assets		—	Other noncurrent liabilities		8,055
Total derivatives designated as hedging instruments		$	5,397		$	8,159

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheet as of June 30, 2024:

	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	7,455	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets		5,151	Other noncurrent liabilities		—
Cross-currency swaps	Prepaid expenses and other current assets		2,376	Accrued expenses and other current liabilities		—
Cross-currency swaps	Other noncurrent assets		—	Other noncurrent liabilities		3,333
Total derivatives designated as hedging instruments		$	14,982		$	3,333

Schedule of Pre-Tax Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL for the three months ended September 30, 2024 and 2023:

Derivatives in Cash Flow Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Reclassified from AOCL into Income	Amount of Gain Reclassified from AOCL into Income
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Interest rate swaps	$	(7,366	)	$	5,478	Interest and other financing expense, net	$	2,336	$	2,281
Foreign currency forward contracts		—			41	Cost of sales		—		—
	$	(7,366	)	$	5,519		$	2,336	$	2,281

The following table presents the pre-tax effect of fair value hedge accounting on AOCL for the three months ended September 30, 2024 and 2023:

Derivatives in Fair value Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Cross-currency swaps	$	(809	)	$	572	Interest and other financing expense, net	$	123	$	123
	$	(809	)	$	572		$	123	$	123

Schedule of Pre-Tax Effect of Derivative Financial Instruments Electing Cash Flow Hedge Accounting on Consolidated Statements of Operations

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the consolidated statements of operations for the three months ended of September 30, 2024 and 2023:

	Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023
	Interest and other financing expense, net		Interest and other financing expense, net
The effects of cash flow hedging:
Gain on cash flow hedging relationships
Interest rate swaps
Amount of gain reclassified from AOCL into income	$	2,336	$	2,281

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing fair value hedge accounting on the consolidated statements of operations as of September 30, 2024 and 2023:

	Location and Amount of (Loss) Gain Recognized in the Consolidated Statements of Operations on Fair Value Hedging Relationships
	Three Months Ended September 30, 2024			Three Months Ended September 30, 2023
	Interest and other financing expense, net			Interest and other financing expense, net
The effects of fair value hedging:
Gain on fair value hedging relationships
Cross-currency swaps
Amount of (loss) gain reclassified from AOCL into (expense) income	$	(960	)	$	953

Schedule of Pre-Tax Effect of Net Investment Hedges on Accumulated Other Comprehensive Loss and the Consolidated Statements of Operations

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the consolidated statements of operations for the three months ended September 30, 2024 and 2023:

Derivatives in Net Investment Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives					Location of Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended September 30,						Three Months Ended September 30,
	2024			2023			2024		2023
Cross-currency swaps	$	(3,282	)	$	2,316	Interest and other financing expense, net	$	495	$	495

XML

Transformation Program - Hain Reimagined (Tables)

3 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Activity and Liability Balances

The table below sets forth expenses associated with the Hain Reimagined Program for the period ended September 30, 2024 and September 30, 2023 by reportable segments and Corporate and Other.

	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023
North America	$	2,241	$	3,358
Corporate and Other		1,990		5,770
International		1,194		595
	$	5,425	$	9,723

The following table displays the activities and liability balances relating to the Hain Reimagined Program for the period ended as of September 30, 2024. The Company expects to pay the remaining accrued restructuring costs during the next 12 months.

	Balance at June 30, 2024		Charges		Amounts Paid			Non-cash settlements/ Adjustments			Balance at September 30, 2024
Employee-related costs	$	1,985	$	2,280	$	(2,820	)	$	—		$	1,445
Contract termination costs		347		367		(8	)		(70	)		636
Asset write-downs1		—		31		—			(31	)		—
Other transformation-related expenses2		3,988		2,747		(2,454	)		(600	)		3,681
	$	6,320	$	5,425	$	(5,282	)	$	(701	)	$	5,762

1Represents non-cash asset write-downs including asset impairment and accelerated depreciation.
2Other transformation-related expenses primarily include consultancy charges related to reorganization of global functions and related personnel resource requirements, and rationalizing sourcing and supply chain processes.

XML

Segment Information (Tables)

3 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The following tables set forth financial information about each of the Company’s reportable segments. Information about total assets by segment is not disclosed because such information is not reported to or used by the Company’s CODM for purposes of assessing segment performance or allocating resources. Transactions between reportable segments were insignificant for all periods presented.

	Three Months Ended September 30,
	2024			2023
Net Sales:
North America	$	231,140		$	260,054
International		163,456			164,975
	$	394,596		$	425,029
Adjusted EBITDA:
North America	$	12,459		$	18,727
International		20,370			17,438
Total Reportable Segments Adjusted EBITDA		32,829			36,165
Corporate and Other		(10,454	)		(12,075	)
		22,375			24,090
Depreciation and amortization		(11,427	)		(12,305	)
Equity in net loss of equity-method investees		(155	)		(498	)
Interest expense, net		(12,995	)		(12,623	)
(Provision) benefit for income taxes		(3,523	)		5,379
Stock-based compensation, net		(2,876	)		(3,742	)
Unrealized currency losses		(1,194	)		(35	)
Certain litigation expenses, net(a)		(827	)		(1,524	)
Restructuring activities
Productivity and transformation costs		(5,018	)		(6,403	)
Plant closure related costs, net		(376	)		(1,841	)
Acquisitions, divestitures and other
Loss on sale of assets		(3,934	)		(62	)
Transaction and integration costs, net		318			(118	)
Impairment charges
Long-lived asset impairment		(31	)		(694	)
Net loss	$	(19,663	)	$	(10,376	)

(a) Expenses and items relating to securities class action, baby food litigation and SEC investigation.

Schedule of Net Sales by Product Category

The Company’s net sales by product category are as follows:

	Three Months Ended September 30,
	2024		2023
Snacks	$	99,475	$	117,088
Baby & Kids		60,768		62,528
Beverages		56,676		56,148
Meal preparation		159,392		165,196
Personal care		18,285		24,069
	$	394,596	$	425,029

Schedule of Net Sales by Geographic Region

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, are as follows:

	Three Months Ended September 30,
	2024		2023
United States	$	202,773	$	230,659
United Kingdom		122,406		121,051
Western Europe		41,050		43,924
Canada		28,367		29,395
	$	394,596	$	425,029

XML

Business (Details)	3 Months Ended
	Sep. 30, 2024 Segment Country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments | Segment	2
Number of countries product marketed and sold | Country	70

XML

Basis of Presentation (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Accounting Policies [Abstract]
Accounts receivable sold, principal	$ 56,959	$ 86,506

XML

Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net loss	$ (19,663)	$ (10,376)
Denominator:
Basic weighted average shares outstanding (shares)	89,861	89,512
Diluted weighted average shares outstanding (shares)	89,861	89,512
Basic net loss per common share (USD per share)	$ (0.22)	$ (0.12)
Diluted net loss per common share (USD per share)	$ (0.22)	$ (0.12)

XML

Disposition - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Aug. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Goodwill, written off related to sale of business unit	$ 7,280
Pretax loss on sale of assets	3,934	$ 62
ParmCrisps | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration to be received for sale of business			$ 12,000
Goodwill, written off related to sale of business unit	7,280
Inventory, written off related to sale of business unit	6,725
Machinery and equipment, written off related to sale of business unit	1,282
Other expense (income), net | ParmCrisps | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pretax loss on sale of assets	$ (3,863)

XML

Inventories - Schedule of Components of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Inventory Disclosure [Abstract]
Finished goods	$ 178,863	$ 178,150
Raw materials, work-in-progress, and packaging	91,555	95,978
Total inventories	$ 270,418	$ 274,128

XML

Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 532,345	$ 520,705
Less: Accumulated depreciation	265,398	258,975
Property, plant and equipment, net	266,947	261,730
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	11,738	11,381
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	59,381	57,030
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	335,138	325,174
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	54,940	54,139
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	21,830	20,943
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	37,784	39,255
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 11,534	$ 12,783

XML

Property, Plant and Equipment, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Line Items]
Depreciation	$ 7,910	$ 9,826

XML

Leases - Schedule of Lease Expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Operating lease expenses	$ 4,109	$ 4,578
Finance lease expenses	37	37
Variable lease expenses	173	182
Short-term lease expenses	426	395
Total lease expenses	$ 4,745	$ 5,192

XML

Goodwill and Other Intangible Assets - Schedule of Changes In Carrying Amount Of Goodwill (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2024 USD ($)
Goodwill
Beginning balance, goodwill	$ 929,304
Divestiture	(7,280)
Translation	14,317
Ending balance, goodwill	936,341
North America
Goodwill
Beginning balance, goodwill	689,468
Divestiture	(7,280)
Translation	514
Ending balance, goodwill	682,702
International
Goodwill
Beginning balance, goodwill	239,836
Divestiture	0
Translation	13,803
Ending balance, goodwill	$ 253,639

XML

Goodwill and Other Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024
Goodwill [Line Items]
Accumulated impairment charge		$ 134,277
Divestiture	$ 7,280
North America
Goodwill [Line Items]
Accumulated impairment charge		7,700
Divestiture	7,280
International
Goodwill [Line Items]
Accumulated impairment charge		$ 126,577
Divestiture	0
ParmCrisps | Disposed of by Sale
Goodwill [Line Items]
Divestiture	$ 7,280

XML

Goodwill and Other Intangible Assets - Components Of Trademarks And Other Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Amortized intangible assets:
Other intangibles	$ 169,560	$ 167,886
Less: Accumulated amortization	(120,788)	(118,324)
Net amortized intangible assets	48,772	49,562
Net other intangible assets	250,179	244,799
Trademarks and Tradenames
Non-amortized intangible assets:
Trademarks and tradenames	$ 201,407	$ 195,237

XML

Goodwill and Other Intangible Assets - Components Of Trademarks And Other Intangible Assets (Parenthetical) (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Trademarks and Tradenames
Finite-Lived Intangible Assets [Line Items]
Accumulated impairment charges	$ 251,551	$ 251,551

XML

Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Finite-Lived Intangible Assets [Line Items]
Remaining amortization period (in years)	8 years 8 months 12 days
Goodwill	$ 936,341	$ 929,304
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)	7 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)	25 years
U. S. Reporting Unit
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 633,774

XML

Goodwill and Other Intangible Assets - Schedule of Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangibles	$ 2,180	$ 1,955

XML

Debt and Borrowings - Summary of Debt and Borrowings (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Line of Credit Facility [Line Items]
Less: Unamortized issuance costs	$ (1,510)	$ (1,680)
Other borrowings	201	222
Long-term debt	740,366	744,092
Short-term borrowings and current portion of long-term debt	7,567	7,569
Long-term debt, less current portion	732,799	736,523
Second Amendment and Restated Credit Agreement | Term loans
Line of Credit Facility [Line Items]
Debt, gross	268,675	270,550
Second Amendment and Restated Credit Agreement | Revolving credit facility | Line of Credit
Line of Credit Facility [Line Items]
Debt, gross	$ 473,000	$ 475,000

XML

Debt and Borrowings - Summary of Debt and Borrowings (Parenthetical) (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Debt Disclosure [Abstract]
Total lease liabilities	$ 201	$ 222
Current finance liabilities	$ 83	$ 85

XML

Debt and Borrowings - Additional Information (Details) $ in Thousands	3 Months Ended		13 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Jan. 01, 2025	Dec. 31, 2024	Jun. 30, 2024 USD ($)	Dec. 31, 2023	Aug. 22, 2023 USD ($)	Dec. 31, 2022 USD ($)
Line of Credit Facility [Line Items]
Interest paid	$ 12,455	$ 11,432
Interest Rate Swap | Cash Flow Hedging
Line of Credit Facility [Line Items]
Notional amount	$ 400,000		$ 400,000
Derivative fixed interest rate	5.60%		5.60%
Line of Credit | Revolving Credit Facility
Line of Credit Facility [Line Items]
Debt issuance costs, gross									$ 5,841
Second Amendment and Restated Credit Agreement
Line of Credit Facility [Line Items]
Revolving credit facility								$ 1,100,000
Deferred debt issuance costs		5,729
Second Amendment and Restated Credit Agreement | Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate			2.50%
Second Amendment and Restated Credit Agreement | Secured Overnight Financing Rate | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.125%
Second Amendment and Restated Credit Agreement | Secured Overnight Financing Rate | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate			2.00%
Second Amendment and Restated Credit Agreement | Base Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.50%
Second Amendment and Restated Credit Agreement | Base Rate | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate			0.125%
Second Amendment and Restated Credit Agreement | Base Rate | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.00%
Second Amendment and Restated Credit Agreement | Term loans
Line of Credit Facility [Line Items]
Face amount								$ 300,000
Debt, gross	$ 268,675		$ 268,675
Deferred debt issuance costs		$ 1,531
Second Amendment and Restated Credit Agreement | Line of Credit
Line of Credit Facility [Line Items]
Weighted average interest rate	7.76%		7.76%
Weighted average interest rate, including hedge impact	6.56%		6.56%
Second Amendment and Restated Credit Agreement | Line of Credit | Minimum
Line of Credit Facility [Line Items]
Consolidated secured leverage ratio covenant								2.5
Commitment fee percentage	0.15%
Second Amendment and Restated Credit Agreement | Line of Credit | Maximum
Line of Credit Facility [Line Items]
Consolidated secured leverage ratio covenant		5					5.25	6
Commitment fee percentage	0.25%
Second Amendment and Restated Credit Agreement | Line of Credit | Forecast | Maximum
Line of Credit Facility [Line Items]
Consolidated secured leverage ratio covenant				4.25	5
Second Amendment and Restated Credit Agreement | Line of Credit | Revolving Credit Facility
Line of Credit Facility [Line Items]
Revolving credit facility								$ 800,000
Debt, gross	$ 473,000		$ 473,000			$ 475,000
Debt issuance costs, gross		$ 5,841
Deferred debt issuance costs		$ 4,198
Second Amendment and Restated Credit Agreement | Line of Credit | Revolving Credit Facility | United States
Line of Credit Facility [Line Items]
Revolving credit facility								440,000
Second Amendment and Restated Credit Agreement | Line of Credit | Revolving Credit Facility | Global
Line of Credit Facility [Line Items]
Revolving credit facility								$ 360,000
Amended and Restated Credit Agreement | Letter of credit
Line of Credit Facility [Line Items]
Letters of credit outstanding	3,247		3,247
Amended and Restated Credit Agreement | Line of Credit
Line of Credit Facility [Line Items]
Available borrowing capacity	$ 323,753		$ 323,753
First Amendment and Restated Credit Agreement
Line of Credit Facility [Line Items]
Deferred debt issuance costs									5,729
First Amendment and Restated Credit Agreement | Term loans
Line of Credit Facility [Line Items]
Deferred debt issuance costs									1,531
First Amendment and Restated Credit Agreement | Line of Credit | Revolving Credit Facility
Line of Credit Facility [Line Items]
Deferred debt issuance costs									$ 4,198

XML

Income Taxes - Additional Information (Details)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation (as a percent)	22.00%	(35.30%)

XML

Accumulated Other Comprehensive Loss - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 942,913	$ 1,017,907
Other comprehensive (loss) income before reclassifications	39,237	(26,603)
Amounts reclassified into (income) expense	(1,401)	(2,804)
Total other comprehensive income (loss)	37,836	(29,407)
Ending balance	963,661	980,994
Accumulated Other Comprehensive Loss
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(137,245)	(126,216)
Ending balance	(99,409)	(155,623)
Foreign Currency Translation Adjustment, Net
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(147,073)	(138,028)
Other comprehensive (loss) income before reclassifications	47,815	(32,933)
Amounts reclassified into (income) expense	0	0
Total other comprehensive income (loss)	47,815	(32,933)
Ending balance	(99,258)	(170,961)
Deferred Gains (Losses) on Cash Flow Hedging Instruments, Net
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	9,395	10,898
Other comprehensive (loss) income before reclassifications	(5,515)	4,159
Amounts reclassified into (income) expense	(1,749)	(1,715)
Total other comprehensive income (loss)	(7,264)	2,444
Ending balance	2,131	13,342
Deferred Gains (Losses) on Fair Value Hedging Instruments, Net
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	297	685
Other comprehensive (loss) income before reclassifications	(606)	430
Amounts reclassified into (income) expense	719	(717)
Total other comprehensive income (loss)	113	(287)
Ending balance	410	398
Deferred Gains (Losses) on Net Investment Hedging Instruments, Net
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	136	229
Other comprehensive (loss) income before reclassifications	(2,457)	1,741
Amounts reclassified into (income) expense	(371)	(372)
Total other comprehensive income (loss)	(2,828)	1,369
Ending balance	$ (2,692)	$ 1,598

XML

Stock-Based Compensation and Incentive Performance Plans - Schedule of Compensation Cost And Related Income Tax Benefits Recognized (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Related income tax benefit	$ 283	$ 456
Selling, General and Administrative Expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 2,876	$ 3,742

XML

Stock-Based Compensation and Incentive Performance Plans - Schedule of All Stock-Based Award Activity (Details) - RSUs and PSUs shares in Thousands	3 Months Ended
	Sep. 30, 2024 $ / shares shares
Number of Shares and Units
Non-vested at beginning of period - RSUs and PSUs (shares) | shares	2,165
Granted (shares) | shares	12
Vested (shares) | shares	(97)
Forfeited (shares) | shares	(69)
Non-vested at end of period - RSUs and PSUs (shares) | shares	2,011
Weighted Average Grant Date Fair  Value (per share)
Non-vested at beginning of period - RSUs and PSUs (USD per share) | $ / shares	$ 15.03
Granted (USD per share) | $ / shares	7
Vested (USD per share) | $ / shares	18.15
Forfeited (USD per share) | $ / shares	15.14
Non-vested at end of period - RSUs and PSUs (USD per share) | $ / shares	$ 14.83

XML

Stock-Based Compensation and Incentive Performance Plans - Additional Information (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2024 USD ($)
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 15,518
Period for recognition (in years)	1 year 9 months 18 days
2022-2024 LTIP | Minimum | Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of targeted award (as a percent)	0.00%
2022-2024 LTIP | Maximum | Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of targeted award (as a percent)	200.00%

XML

Stock-Based Compensation and Incentive Performance Plans - Schedule of Restricted Stock Grant Information (Details) - RSUs - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of RSUs granted	$ 86	$ 0
Fair value of shares vested	823	2,422
Tax benefit recognized from restricted stock vesting	$ 100	$ 281

XML

Financial Instruments Measured At Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Assets:
Derivative financial instruments	$ 5,397	$ 14,982
Liabilities:
Derivative financial instruments	8,159	3,333
Quoted prices in active markets (Level 1)
Assets:
Derivative financial instruments	0	0
Liabilities:
Derivative financial instruments	0	0
Significant other observable inputs (Level 2)
Assets:
Derivative financial instruments	5,397	14,982
Liabilities:
Derivative financial instruments	8,159	3,333
Significant unobservable inputs (Level 3)
Assets:
Derivative financial instruments	0	0
Liabilities:
Derivative financial instruments	$ 0	$ 0

XML

Financial Instruments Measured At Fair Value - Additional Information (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Fair value, assets, level 1 to level 2 transfers, amount	$ 0	$ 0
Fair value, liabilities, level 1 to level 2 transfers, amount	0	0
Fair value, assets, level 2 to level 1 transfers, amount	0	0
Fair value, liabilities, level 2 to level 1 transfers, amount	0	0
Fair value assets level 3 to level 1 transfers, amount	0	0
Fair value liabilities level 3 to level 1 transfers, amount	$ 0	$ 0

XML

Derivatives and Hedging Activities - Additional Information (Details)	12 Months Ended
	Sep. 30, 2025 USD ($)	Sep. 30, 2024 ForeignCurrencyDerivative
Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Foreign currency derivatives | ForeignCurrencyDerivative		0
Forecast | Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other comprehensive income (loss), cash flow hedge, reclassification	$ 3,010,000
Forecast | Cross Currency Swap | Fair Value Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other comprehensive income (loss), cash flow hedge, reclassification	476,000
Forecast | Cross Currency Swap | Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Expense	$ 0

XML

Derivatives and Hedging Activities - Schedule of Derivative Information (Details) € in Thousands, $ in Thousands	Sep. 30, 2024 USD ($) Instrument	Sep. 30, 2024 EUR (€) Instrument
Interest Rate Swap | Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of instruments | Instrument	4	4
Notional amount | $	$ 400,000
Cross-currency swaps | Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of instruments | Instrument	4	4
Cross-currency swaps | Net Investment Hedging | Short
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount | €		€ 100,300
Cross-currency swaps | Net Investment Hedging | Long
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount | $	$ 105,804
Cross-currency swaps | Fair Value Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of instruments | Instrument	1	1
Cross-currency swaps | Fair Value Hedging | Short
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount | €		€ 24,700
Cross-currency swaps | Fair Value Hedging | Long
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount | $	$ 26,021

XML

Derivatives and Hedging Activities - Schedule of Fair Value Hedges (Details) - Intercompany loan receivable - Fair Value Hedging - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying Amount of the Hedged Asset	$ 27,548	$ 26,465
Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset	$ 1,083	$ (480)

XML

Derivatives and Hedging Activities - Schedule of Balance Sheet Location (Details) - Designated as Hedging Instrument - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 5,397	$ 14,982
Derivative liability, fair value	8,159	3,333
Prepaid expenses and other current assets | Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	3,008	7,455
Prepaid expenses and other current assets | Cross-currency swaps
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	2,389	2,376
Other noncurrent assets | Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	0	5,151
Other noncurrent assets | Cross-currency swaps
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	0	0
Accrued expenses and other current liabilities | Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	0
Accrued expenses and other current liabilities | Cross-currency swaps
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	0
Other noncurrent liabilities | Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	104	0
Other noncurrent liabilities | Cross-currency swaps
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	$ 8,055	$ 3,333

XML

Derivatives and Hedging Activities - Schedule of Cash Flow Hedges and Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in AOCL on Derivatives	$ (7,366)	$ 5,519
Cost of sales	312,986	341,086
Reclassification out of Accumulated Other Comprehensive Income | Deferred Gains on Cash Flow Hedging Instruments, Net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain Reclassified from AOCL into Income	2,336	2,281
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in AOCL on Derivatives	(7,366)	5,478
Interest Rate Swap | Reclassification out of Accumulated Other Comprehensive Income | Deferred Gains on Cash Flow Hedging Instruments, Net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net	2,336	2,281
Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in AOCL on Derivatives	0	41
Foreign currency forward contracts | Reclassification out of Accumulated Other Comprehensive Income | Deferred Gains on Cash Flow Hedging Instruments, Net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cost of sales	$ 0	$ 0

XML

Derivatives and Hedging Activities - Schedule of Pre-Tax Effect of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Interest Rate Swap | Interest and other financing expense, net | Reclassification out of Accumulated Other Comprehensive Income | Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of gain reclassified from AOCL into income	$ 2,336	$ 2,281

XML

Derivatives and Hedging Activities - Schedule of Fair Value Hedges and Accumulated Other Comprehensive Loss (Details) - Fair Value Hedging - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	$ (809)	$ 572
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain Loss From Fair Value Hedges Attributable To Parent
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net	123	123
Cross-currency swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	(809)	572
Cross-currency swaps | Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain Loss From Fair Value Hedges Attributable To Parent
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net	123	123
Cross-currency swaps | Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain Loss From Fair Value Hedges Attributable To Parent | Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (loss) gain reclassified from AOCL into (expense) income	$ (960)	$ 953

XML

Derivatives and Hedging Activities - Schedule of Net Investment Hedges and Accumulated Other Comprehensive Loss (Details) - Cross-currency swaps - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in AOCL on Derivatives	$ (3,282)	$ 2,316
Net Investment Hedging | Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of (Loss) Gain Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	$ 495	$ 495

XML

Transformation Program - Hain Reimagined - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring charges recorded in productivity and transformation costs	$ 5,018	$ 6,403
Restructuring charges recorded in cost of sales	376	$ 3,320
Restructuring charges recorded in intangibles and long lived asset impairment	$ 31
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Asset Impairment Charges, Cost of Goods and Services Sold, Property Plant And Equipment, Removal Of Machinery Expense	Cost of Goods and Services Sold, Property Plant And Equipment, Removal Of Machinery Expense

XML

Transformation Program - Hain Reimagined - Schedule of Restructuring Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 5,425	$ 9,723
North America
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2,241	3,358
International
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,194	595
Corporate and Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 1,990	$ 5,770

XML

Transformation Program - Hain Reimagined - Schedule of Restructuring Activity and Liability Balances (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	$ 6,320
Charges	5,425	$ 9,723
Amounts Paid	(5,282)
Non-cash settlements/Adjustments	(701)
Restructuring Reserve, Ending Balance	5,762
Employee-related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	1,985
Charges	2,280
Amounts Paid	(2,820)
Non-cash settlements/Adjustments	0
Restructuring Reserve, Ending Balance	1,445
Contract termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	347
Charges	367
Amounts Paid	(8)
Non-cash settlements/Adjustments	(70)
Restructuring Reserve, Ending Balance	636
Asset write-downs
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	0
Charges	31
Amounts Paid	0
Non-cash settlements/Adjustments	(31)
Restructuring Reserve, Ending Balance	0
Other transformation-related expenses
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	3,988
Charges	2,747
Amounts Paid	(2,454)
Non-cash settlements/Adjustments	(600)
Restructuring Reserve, Ending Balance	$ 3,681

XML

Commitments and Contingencies - Additional Information (Details)	Dec. 29, 2021	Dec. 20, 2017	Aug. 17, 2016 Complaint	Sep. 30, 2024 Case Federalcase	Nov. 30, 2023 Business
Loss Contingencies [Line Items]
Temporary stay, period after court decision		30 days
Number of cases pending in MDL (approximately) | Federalcase				24
Number of cases pending in California state court | Case				7
Number of business acquisitions subject to SEC investigation | Business					1
Securities Class Action Complaints
Loss Contingencies [Line Items]
Number of complaints | Complaint			3
Barnes Complaint
Loss Contingencies [Line Items]
Temporary stay, period after court decision	30 days

XML

Segment Information - Additional Information (Details)	3 Months Ended	12 Months Ended
	Sep. 30, 2024 Segment	Jun. 30, 2024 USD ($)
Segment Reporting [Abstract]
Number of reportable segments	2
Number of operating segments	2
Changes in total assets | $		$ 0

XML

Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net sales	$ 394,596	$ 425,029
Adjusted EBITDA	22,375	24,090
Depreciation and amortization	(11,427)	(12,305)
Equity in net loss of equity-method investees	(155)	(498)
Interest expense, net	(12,995)	(12,623)
(Provision) benefit for income taxes	(3,523)	5,379
Stock-based compensation, net	(2,876)	(3,742)
Unrealized currency losses	(1,194)	(35)
Certain litigation expenses, net	(827)	(1,524)
Acquisitions, divestitures and other
Loss on sale of assets	(3,934)	(62)
Transaction and integration costs, net	318	(118)
Impairment charges
Long-lived asset impairment	(31)	(694)
Net loss	(19,663)	(10,376)
Plant closure related costs, net
Restructuring activities
Restructuring activities	(376)	(1,841)
Productivity and transformation costs
Restructuring activities
Restructuring activities	(5,018)	(6,403)
Operating Segments
Segment Reporting Information [Line Items]
Net sales	394,596	425,029
Adjusted EBITDA	32,829	36,165
Operating Segments | North America
Segment Reporting Information [Line Items]
Net sales	231,140	260,054
Adjusted EBITDA	12,459	18,727
Operating Segments | International
Segment Reporting Information [Line Items]
Net sales	163,456	164,975
Adjusted EBITDA	20,370	17,438
Corporate and Other
Segment Reporting Information [Line Items]
Adjusted EBITDA	$ (10,454)	$ (12,075)

XML

Segment Information - Schedule of Net Sales by Product Category (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 394,596	$ 425,029
Snacks
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	99,475	117,088
Baby/Kids
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	60,768	62,528
Beverages
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	56,676	56,148
Meal preparation
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	159,392	165,196
Personal care
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 18,285	$ 24,069

XML

Segment Information - Schedule of Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 394,596	$ 425,029
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	202,773	230,659
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	122,406	121,051
Western Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	41,050	43,924
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 28,367	$ 29,395